AUROPHARMA - Aurobindo Pharma Limited
Aurobindo Pharma Limited Share Market Related News
-: Stock News :- AUROPHARMA 09-06-2022 To 09-06-2022
✔️ Aurobindo Pharma approves fourth interim dividend of 4.50 per share
-: Stock News :- AUROPHARMA 07-06-2022 To 07-06-2022
✔️ Eugia Pharma gets USFDA nod for prostate cancer drug
-: Stock News :- AUROPHARMA 03-06-2022 To 03-06-2022
✔️ Near-term growth issues and cost pressure could impact Aurobindo Pharma
-: Stock News :- AUROPHARMA 01-06-2022 To 01-06-2022
✔️ Near-term growth and cost challenges to weigh on Aurobindo Pharma stock
-: Stock News :- AUROPHARMA 30-05-2022 To 30-05-2022
✔️ Aurobindo Pharma Q4 net profit falls 28% to Rs 576 cr; revenue dips 3%
✔️ Aurobindo Pharma Q4 net down 28%
✔️ Aurobindo Pharma's Q4 net profit down 28%, revenue slips to Rs 5,809 crore
-: Stock News :- AUROPHARMA 11-05-2022 To 30-05-2022
✔️ Aurobindo Pharma hits 52-week low after six observations from US
✔️ Aurobindo Pharma Q4 net down 28%
✔️ Aurobindo Pharma's Q4 net profit down 28%, revenue slips to Rs 5,809 crore
-: Stock News :- AUROPHARMA 04-05-2022 To 30-05-2022
✔️ Aurobindo Pharma gets USFDA nod to market generic cancer drug Bortezomib
✔️ Aurobindo Pharma Q4 net down 28%
✔️ Aurobindo Pharma's Q4 net profit down 28%, revenue slips to Rs 5,809 crore
-: Stock News :- AUROPHARMA 03-05-2022 To 30-05-2022
✔️ Aurobindo Pharma gets USFDA nod for generic cancer drug Bortezomib
✔️ Aurobindo Pharma Q4 net down 28%
✔️ Aurobindo Pharma's Q4 net profit down 28%, revenue slips to Rs 5,809 crore
-: Stock News :- AUROPHARMA 14-04-2022 To 30-05-2022
✔️ Aurobindo Pharma Q4 PAT may dip 26.6% YoY to Rs 588.1 cr: Prabhudas Lilladher
✔️ Aurobindo Pharma Q4 net down 28%
✔️ Aurobindo Pharma's Q4 net profit down 28%, revenue slips to Rs 5,809 crore
-: Stock News :- AUROPHARMA 28-03-2022 To 28-03-2022
✔️ Aurobindo Pharma acquires Veritaz' domestic business for Rs 171 cr
✔️ Aurobindo Pharma acquires Veritaz Healthcare for Rs 171 crore
✔️ Aurobindo Pharma buys domestic formulation business of Veritaz for 171 cr
✔️ Aurobindo Pharma acquires Veritaz formulation business for Rs 171 crore
-: Stock News :- AUROPHARMA 17-02-2022 To 28-03-2022
✔️ Buy Aurobindo Pharma; target of Rs 875: Sharekhan
✔️ Aurobindo Pharma acquires Veritaz Healthcare for Rs 171 crore
✔️ Aurobindo Pharma buys domestic formulation business of Veritaz for 171 cr
✔️ Aurobindo Pharma acquires Veritaz formulation business for Rs 171 crore
-: Stock News :- AUROPHARMA 15-02-2022 To 28-03-2022
✔️ Accumulate Aurobindo Pharma; target of Rs 759: Prabhudas Lilladher
✔️ Accumulate Aurobindo Pharma; target of Rs 756: KR Choksey
✔️ Aurobindo Pharma buys domestic formulation business of Veritaz for 171 cr
✔️ Aurobindo Pharma acquires Veritaz formulation business for Rs 171 crore
-: Stock News :- AUROPHARMA 11-02-2022 To 28-03-2022
✔️ Will the Street reward Aurobindo Pharma's bet on domestic formulations?
✔️ Accumulate Aurobindo Pharma; target of Rs 756: KR Choksey
✔️ Aurobindo Pharma buys domestic formulation business of Veritaz for 171 cr
✔️ Aurobindo Pharma acquires Veritaz formulation business for Rs 171 crore
-: Stock News :- AUROPHARMA 09-02-2022 To 28-03-2022
✔️ Aurobindo Pharma net profit dips 22% to Rs 604 cr in December quarter
✔️ Accumulate Aurobindo Pharma; target of Rs 756: KR Choksey
✔️ Aurobindo Pharma buys domestic formulation business of Veritaz for 171 cr
✔️ Aurobindo Pharma acquires Veritaz formulation business for Rs 171 crore
-: Stock News :- AUROPHARMA 27-01-2022 To 28-03-2022
✔️ USFDA pulls up Aurobindo Pharma for manufacturing lapses at API plant
✔️ USFDA pulls up Aurobindo Pharma for manufacturing lapses at API plant
✔️ Aurobindo Pharma buys domestic formulation business of Veritaz for 171 cr
✔️ Aurobindo Pharma acquires Veritaz formulation business for Rs 171 crore
-: Stock News :- AUROPHARMA 14-01-2022 To 28-03-2022
✔️ Aurobindo Pharma down 5% on USFDA warning letter for Hyderabad unit
✔️ Aurobindo Pharma gets warning letter from USFDA for API facility
✔️ Aurobindo Pharma falls over 3% after bulk drug manufacturing unit receives warning letter from US
✔️ Aurobindo Pharma acquires Veritaz formulation business for Rs 171 crore
-: Stock News :- AUROPHARMA 13-01-2022 To 28-03-2022
✔️ Aurobindo Pharma Q3 PAT may dip 73% YoY to Rs 795.3 cr: Prabhudas Lilladher
✔️ Aurobindo Pharma gets warning letter from USFDA for API facility
✔️ Aurobindo Pharma falls over 3% after bulk drug manufacturing unit receives warning letter from US
✔️ Aurobindo Pharma acquires Veritaz formulation business for Rs 171 crore
-: Stock News :- AUROPHARMA 11-01-2022 To 28-03-2022
✔️ Aurobindo Pharma arm CuraTeQ expands scope of distribution pact with Orion
✔️ Aurobindo Pharma arm CuraTeQ expands scope of distribution pact with Orion
✔️ Aurobindo Pharma falls over 3% after bulk drug manufacturing unit receives warning letter from US
✔️ Aurobindo Pharma acquires Veritaz formulation business for Rs 171 crore
-: Stock News :- AUROPHARMA 06-01-2022 To 28-03-2022
✔️ Aurobindo Pharma launches Molnupiravir at 50 per capsule
✔️ Aurobindo Pharma launches COVID-19 drug Molnupiravir in India
✔️ Aurobindo Pharma falls over 3% after bulk drug manufacturing unit receives warning letter from US
✔️ Aurobindo Pharma acquires Veritaz formulation business for Rs 171 crore
-: Stock News :- AUROPHARMA 05-12-2021 To 28-03-2022
✔️ Aurobindo Pharma, Unichem Laboratories recall products in US market
✔️ Aurobindo Pharma launches COVID-19 drug Molnupiravir in India
✔️ Aurobindo Pharma falls over 3% after bulk drug manufacturing unit receives warning letter from US
✔️ Aurobindo Pharma acquires Veritaz formulation business for Rs 171 crore
-: Stock News :- AUROPHARMA 10-11-2021 To 08-11-2021
✔️ Aurobindo Pharma shares rise after global brokerage upgrades stock to 'buy'
✔️ Aurobindo Pharma bullish on export of Covid drug molnupiravir, its potential in the domestic market
✔️ Aurobindo Pharma posts encouraging US sales recovery during Q2
✔️ Aurobindo Pharma results: Q2 net profit down 14% to Rs 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
✔️ Aurobindo Pharma's Q2 net down 2.1% at 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
-: Stock News :- AUROPHARMA 06-10-2021 To 08-11-2021
✔️ Aurobindo Pharma Q2 PAT may dip 17.3% YoY to Rs 666.3 cr: Prabhudas Lilladher
✔️ Aurobindo Pharma bullish on export of Covid drug molnupiravir, its potential in the domestic market
✔️ Aurobindo Pharma posts encouraging US sales recovery during Q2
✔️ Aurobindo Pharma results: Q2 net profit down 14% to Rs 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
✔️ Aurobindo Pharma's Q2 net down 2.1% at 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
-: Stock News :- AUROPHARMA 04-10-2021 To 08-11-2021
✔️ Aurobindo MD's exit alone may not lift stock, new team must start well
✔️ Drug makers Glenmark, Aurobindo Pharma recall products in US market
✔️ Aurobindo Pharma posts encouraging US sales recovery during Q2
✔️ Aurobindo Pharma results: Q2 net profit down 14% to Rs 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
✔️ Aurobindo Pharma's Q2 net down 2.1% at 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
-: Stock News :- AUROPHARMA 01-10-2021 To 08-11-2021
✔️ Aurobindo Pharma managing director N Govindarajan resigns
✔️ Aurobindo Pharma Managing Director N Govindarajan resigns
✔️ Aurobindo Pharma posts encouraging US sales recovery during Q2
✔️ Aurobindo Pharma results: Q2 net profit down 14% to Rs 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
✔️ Aurobindo Pharma's Q2 net down 2.1% at 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
-: Stock News :- AUROPHARMA 23-09-2021 To 08-11-2021
✔️ Aurobindo Pharma's subsidiary seeks marketing approval of its first biosimilar product from EMA
✔️ Aurobindo Pharma Managing Director N Govindarajan resigns
✔️ Aurobindo Pharma posts encouraging US sales recovery during Q2
✔️ Aurobindo Pharma results: Q2 net profit down 14% to Rs 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
✔️ Aurobindo Pharma's Q2 net down 2.1% at 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
-: Stock News :- AUROPHARMA 27-08-2021 To 08-11-2021
✔️ Two stock recommendations from Osho Krishan of Anand Rathi
✔️ Aurobindo Pharma gets USFDA nod for cancer treatment injection
✔️ Aurobindo Pharma share price up nearly 2% on USFDA approval for an injection
✔️ Aurobindo Pharma results: Q2 net profit down 14% to Rs 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
✔️ Aurobindo Pharma's Q2 net down 2.1% at 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
-: Stock News :- AUROPHARMA 24-08-2021 To 08-11-2021
✔️ Aurobindo Pharma's Cronus rethink is positive, but it needs to do more
✔️ Aurobindo Pharma faces delay in getting its COVID-19 vaccine plan rolling
✔️ Buy Aurobindo Pharma; target of Rs 915: Sharekhan
✔️ Aurobindo Pharma calls off agreement to pick stake in Cronus; stock up 6%
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
✔️ Aurobindo Pharma's Q2 net down 2.1% at 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
-: Stock News :- AUROPHARMA 23-08-2021 To 08-11-2021
✔️ Aurobindo Pharma: Termination of inorganic bet allays capital allocation concerns
✔️ Aurobindo Pharma shares jump 4% after global research firm retains outperform call
✔️ Buzzing Stocks: Aurobindo Pharma, CarTrade, Cadila Healthcare and other stocks in news today
✔️ Aurobindo Pharma calls off agreement to pick stake in Cronus; stock up 6%
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
✔️ Aurobindo Pharma's Q2 net down 2.1% at 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
-: Stock News :- AUROPHARMA 20-08-2021 To 08-11-2021
✔️ Aurobindo Pharma Unit-1 gets 7 observations; company says responding to USFDA
✔️ Deal to acquire 51% stake in vet drug firm Cronus cancelled: Aurobindo Pharma
✔️ Aurobindo Pharma says Rs 450-crore deal to acquire 51% in Cronus Pharma cancelled
✔️ Aurobindo Pharma's Rs 450-cr deal to acquire 51% in Cronus Pharma cancelled
✔️ Aurobindo Pharma, Cronus Pharma terminate acquisition deal
✔️ Aurobindo Pharma's Q2 net down 2.1% at 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
-: Stock News :- AUROPHARMA 17-08-2021 To 08-11-2021
✔️ Aurobindo Pharma hits 52-week low, slips 25% in one month
✔️ Deal to acquire 51% stake in vet drug firm Cronus cancelled: Aurobindo Pharma
✔️ Aurobindo Pharma says Rs 450-crore deal to acquire 51% in Cronus Pharma cancelled
✔️ Aurobindo Pharma's Rs 450-cr deal to acquire 51% in Cronus Pharma cancelled
✔️ Aurobindo Pharma, Cronus Pharma terminate acquisition deal
✔️ Aurobindo Pharma's Q2 net down 2.1% at 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
-: Stock News :- AUROPHARMA 13-08-2021 To 08-11-2021
✔️ Near term upsides for Aurobindo Pharma stock capped on weak US outlook
✔️ Aurobindo Pharma to invest Rs 420 cr in veterinary firm Cronus for 51% stake
✔️ Aurobindo Pharma dips 5% on weak operational performance in June quarter
✔️ Aurobindo Pharma Q1 consolidated net profit declines 2% to Rs 770 crore
✔️ Aurobindo Pharma, Cronus Pharma terminate acquisition deal
✔️ Aurobindo Pharma's Q2 net down 2.1% at 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
-: Stock News :- AUROPHARMA 09-08-2021 To 08-11-2021
✔️ Nutanix India registers 24% growth in Q3, onboards NKGSB, Aurobindo Pharma as clients
✔️ Aurobindo Pharma to invest Rs 420 cr in veterinary firm Cronus for 51% stake
✔️ Aurobindo Pharma dips 5% on weak operational performance in June quarter
✔️ Aurobindo Pharma Q1 consolidated net profit declines 2% to Rs 770 crore
✔️ Aurobindo Pharma, Cronus Pharma terminate acquisition deal
✔️ Aurobindo Pharma's Q2 net down 2.1% at 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
-: Stock News :- AUROPHARMA 05-08-2021 To 08-11-2021
✔️ Aurobindo pharma plans to commercialise Covid19 vaccine, ties up with US-based Vaxxinity
✔️ Aurobindo Pharma looks to commercialise COVID-19 vaccine, expand API production
✔️ Aurobindo Pharma channelising efforts to commercialise COVID-19 vaccine
✔️ Aurobindo Pharma channelising efforts to commercialise Covid-19 vaccine
✔️ Aurobindo Pharma channelising efforts to commercialise COVID-19 vaccine
✔️ Aurobindo Pharma's Q2 net down 2.1% at 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
-: Stock News :- AUROPHARMA 13-07-2021 To 08-11-2021
✔️ Aurobindo Pharma Q1 PAT seen up 1.3% YoY to Rs 791.1 cr: KRChoksey
✔️ Aurobindo Pharma looks to commercialise COVID-19 vaccine, expand API production
✔️ Aurobindo Pharma channelising efforts to commercialise COVID-19 vaccine
✔️ Aurobindo Pharma channelising efforts to commercialise Covid-19 vaccine
✔️ Aurobindo Pharma channelising efforts to commercialise COVID-19 vaccine
✔️ Aurobindo Pharma's Q2 net down 2.1% at 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
-: Stock News :- AUROPHARMA 10-07-2021 To 08-11-2021
✔️ Why you should buy Aurobindo Pharma stock
✔️ Aurobindo Pharma looks to commercialise COVID-19 vaccine, expand API production
✔️ Aurobindo Pharma channelising efforts to commercialise COVID-19 vaccine
✔️ Aurobindo Pharma channelising efforts to commercialise Covid-19 vaccine
✔️ Aurobindo Pharma channelising efforts to commercialise COVID-19 vaccine
✔️ Aurobindo Pharma's Q2 net down 2.1% at 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
-: Stock News :- AUROPHARMA 02-07-2021 To 08-11-2021
✔️ Injectables consolidation could fetch higher valuations for Aurobindo
✔️ Aurobindo Pharma to transfer biz in Unit-4 to arm Eugia Pharma; stock up 4%
✔️ Aurobindo Pharma channelising efforts to commercialise COVID-19 vaccine
✔️ Aurobindo Pharma channelising efforts to commercialise Covid-19 vaccine
✔️ Aurobindo Pharma channelising efforts to commercialise COVID-19 vaccine
✔️ Aurobindo Pharma's Q2 net down 2.1% at 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
-: Stock News :- AUROPHARMA 04-06-2021 To 08-11-2021
✔️ Accumulate Aurobindo Pharma; target of Rs 1044: KR Choksey
✔️ Aurobindo Pharma to transfer biz in Unit-4 to arm Eugia Pharma; stock up 4%
✔️ Aurobindo Pharma channelising efforts to commercialise COVID-19 vaccine
✔️ Aurobindo Pharma channelising efforts to commercialise Covid-19 vaccine
✔️ Aurobindo Pharma channelising efforts to commercialise COVID-19 vaccine
✔️ Aurobindo Pharma's Q2 net down 2.1% at 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
-: Stock News :- AUROPHARMA 02-06-2021 To 31-05-2021
✔️ Buy Aurobindo Pharma target of Rs 1139: Prabhudas Lilladher
✔️ Buy Aurobindo Pharma; target of Rs 1165: ICICI Direct
✔️ Lack of near-term triggers to cap upsides in Aurobindo Pharma
✔️ Aurobindo Pharma Edges Lower After Posting Rs 801 Crore Profit In March Quarter
✔️ Buy Aurobindo Pharma: target of Rs 1185: Sharekhan
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
-: Stock News :- AUROPHARMA 01-06-2021 To 31-05-2021
✔️ What should investors do with Aurobindo Pharma post Q4 results: Buy, sell or hold?
✔️ Aurobindo Pharma Q4 net down 7.2%
✔️ Aurobindo Pharm Consolidated March 2021 Net Sales at Rs 6,001.50 crore, down 2.55% Y-o-Y
✔️ Aurobindo Pharma Edges Lower After Posting Rs 801 Crore Profit In March Quarter
✔️ Buy Aurobindo Pharma: target of Rs 1185: Sharekhan
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
-: Stock News :- AUROPHARMA 22-04-2021 To 31-05-2021
✔️ Strong injectables portfolio to support Aurobindo Pharma's growth
✔️ Aurobindo Pharma Q4 net down 7.2%
✔️ Aurobindo Pharm Consolidated March 2021 Net Sales at Rs 6,001.50 crore, down 2.55% Y-o-Y
✔️ Aurobindo Pharma Edges Lower After Posting Rs 801 Crore Profit In March Quarter
✔️ Buy Aurobindo Pharma: target of Rs 1185: Sharekhan
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
-: Stock News :- AUROPHARMA 12-04-2021 To 31-05-2021
✔️ Aurobindo Q4 PAT seen up 6% YoY to Rs. 901 cr: Sharekhan
✔️ Aurobindo Pharma Q4 net down 7.2%
✔️ Aurobindo Pharm Consolidated March 2021 Net Sales at Rs 6,001.50 crore, down 2.55% Y-o-Y
✔️ Aurobindo Pharma Edges Lower After Posting Rs 801 Crore Profit In March Quarter
✔️ Buy Aurobindo Pharma: target of Rs 1185: Sharekhan
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
-: Stock News :- AUROPHARMA 31-03-2021 To 31-05-2021
✔️ Buy Aurobindo Pharma: target of Rs 1100: Sharekhan
✔️ Aurobindo Pharma Q4 net down 7.2%
✔️ Aurobindo Pharm Consolidated March 2021 Net Sales at Rs 6,001.50 crore, down 2.55% Y-o-Y
✔️ Aurobindo Pharma Edges Lower After Posting Rs 801 Crore Profit In March Quarter
✔️ Buy Aurobindo Pharma: target of Rs 1185: Sharekhan
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
-: Stock News :- AUROPHARMA 19-02-2021 To 31-05-2021
✔️ Aurobindo Pharma hopes to submit Phase 2/3 data of UB-612 COVID-19 vaccine by July 2021
✔️ Aurobindo Pharma gets USFDA nod for generic Droxidopa capsules
✔️ Weekly Tactical Pick | Aurobindo Pharma
✔️ Aurobindo Pharma Edges Lower After Posting Rs 801 Crore Profit In March Quarter
✔️ Buy Aurobindo Pharma: target of Rs 1185: Sharekhan
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
-: Stock News :- AUROPHARMA 16-02-2021 To 31-05-2021
✔️ Buy Aurobindo Pharma; target of Rs 1100: Sharekhan
✔️ Aurobindo Pharma gets USFDA nod for generic Droxidopa capsules
✔️ Weekly Tactical Pick | Aurobindo Pharma
✔️ Aurobindo Pharma Edges Lower After Posting Rs 801 Crore Profit In March Quarter
✔️ Buy Aurobindo Pharma: target of Rs 1185: Sharekhan
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
-: Stock News :- AUROPHARMA 15-02-2021 To 31-05-2021
✔️ Buy Aurobindo Pharma; target of Rs 1165: ICICI Direct
✔️ Aurobindo Pharma gets USFDA nod for generic Droxidopa capsules
✔️ Weekly Tactical Pick | Aurobindo Pharma
✔️ Aurobindo Pharma Edges Lower After Posting Rs 801 Crore Profit In March Quarter
✔️ Buy Aurobindo Pharma: target of Rs 1185: Sharekhan
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
-: Stock News :- AUROPHARMA 12-02-2021 To 31-05-2021
✔️ Covid-19: Aurobindo Pharma working on multiple' vaccines
✔️ Aurobindo Pharma steady as analysts watch numbers for near-term growth
✔️ Aurobindo Pharma: Vaccine and API plans inject add-on growth levers
✔️ Aurobindo Pharma Edges Lower After Posting Rs 801 Crore Profit In March Quarter
✔️ Buy Aurobindo Pharma: target of Rs 1185: Sharekhan
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
-: Stock News :- AUROPHARMA 11-02-2021 To 31-05-2021
✔️ Aurobindo Pharm Standalone December 2020 Net Sales at Rs 3,710.86 crore, up 10.92% Y-o-Y
✔️ Aurobindo Pharm Consolidated December 2020 Net Sales at Rs 6,364.91 crore, up 7.97% Y-o-Y
✔️ Aurobindo Pharma Q3 net profit zooms over 4-fold to Rs 2,946.32 crore
✔️ Aurobindo Pharma Q3 net profit zooms over four-fold to Rs 2,946.32 cr
✔️ Aurobindo Pharma Q3 net up 17% at 836 crore
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
-: Stock News :- AUROPHARMA 25-01-2021 To 31-05-2021
✔️ Aurobindo Pharma's scrip zooms 8%
✔️ Aurobindo Pharma hits 52-week high on approval under PLI
✔️ Aurobindo gains 5% on govt nod for promotion of manufacturing bulk drugs
✔️ Aurobindo Pharma Q3 net profit zooms over four-fold to Rs 2,946.32 cr
✔️ Aurobindo Pharma Q3 net up 17% at 836 crore
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
-: Stock News :- AUROPHARMA 22-01-2021 To 31-05-2021
✔️ Aurobindo, Kinvan, K'taka Antibiotics first to get PLI for drugs
✔️ Aurobindo Pharma, KAPL get nod for promotion of manufacturing bulk drugs
✔️ Aurobindo gains 5% on govt nod for promotion of manufacturing bulk drugs
✔️ Aurobindo Pharma Q3 net profit zooms over four-fold to Rs 2,946.32 cr
✔️ Aurobindo Pharma Q3 net up 17% at 836 crore
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
-: Stock News :- AUROPHARMA 18-01-2021 To 31-05-2021
✔️ Aurobindo Pharma Q3 PAT seen up 17.2% YoY to Rs. 719 cr: Prabhudas Lilladher
✔️ Aurobindo Pharma, KAPL get nod for promotion of manufacturing bulk drugs
✔️ Aurobindo gains 5% on govt nod for promotion of manufacturing bulk drugs
✔️ Aurobindo Pharma Q3 net profit zooms over four-fold to Rs 2,946.32 cr
✔️ Aurobindo Pharma Q3 net up 17% at 836 crore
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
-: Stock News :- AUROPHARMA 28-12-2020 To 31-05-2021
✔️ Here's a Bull Spread Strategy on Aurobindo Pharma by HDFC Securities
✔️ Aurobindo Pharma, KAPL get nod for promotion of manufacturing bulk drugs
✔️ Aurobindo gains 5% on govt nod for promotion of manufacturing bulk drugs
✔️ Aurobindo Pharma Q3 net profit zooms over four-fold to Rs 2,946.32 cr
✔️ Aurobindo Pharma Q3 net up 17% at 836 crore
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
-: Stock News :- AUROPHARMA 24-12-2020 To 31-05-2021
✔️ Aurobindo Pharma, COVAXX to develop COVID-19 vaccine for India, UNICEF
✔️ Aurobindo Pharma To Make,Sell COVAXX's Covid-19 Vaccine for India, UNICEF
✔️ Aurobindo Pharma enters licensing pact with US biotech COVAXX for manufacture, sale of COVID-19 vaccine
✔️ Aurobindo, COVAXX ink deal to develop, commercialise Covid-19 vaccine for India, UNICEF
✔️ Aurobindo Pharma Q3 net up 17% at 836 crore
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
-: Stock News :- AUROPHARMA 18-12-2020 To 31-05-2021
✔️ Buy Aurobindo Pharma: target of Rs 1024: Sharekhan
✔️ Aurobindo Pharma To Make,Sell COVAXX's Covid-19 Vaccine for India, UNICEF
✔️ Aurobindo Pharma enters licensing pact with US biotech COVAXX for manufacture, sale of COVID-19 vaccine
✔️ Aurobindo, COVAXX ink deal to develop, commercialise Covid-19 vaccine for India, UNICEF
✔️ Aurobindo Pharma Q3 net up 17% at 836 crore
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
-: Stock News :- AUROPHARMA 09-12-2020 To 31-05-2021
✔️ Aurobindo Pharma gets USFDA nod for sedative drug
✔️ Aurobindo Pharma To Make,Sell COVAXX's Covid-19 Vaccine for India, UNICEF
✔️ Aurobindo Pharma enters licensing pact with US biotech COVAXX for manufacture, sale of COVID-19 vaccine
✔️ Aurobindo, COVAXX ink deal to develop, commercialise Covid-19 vaccine for India, UNICEF
✔️ Aurobindo Pharma Q3 net up 17% at 836 crore
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
-: Stock News :- AUROPHARMA 01-12-2020 To 31-05-2021
✔️ Aurobindo says Covid-19 vaccine slightly' delayed; exploring collaborations
✔️ Aurobindo Pharma To Make,Sell COVAXX's Covid-19 Vaccine for India, UNICEF
✔️ Aurobindo Pharma enters licensing pact with US biotech COVAXX for manufacture, sale of COVID-19 vaccine
✔️ Aurobindo, COVAXX ink deal to develop, commercialise Covid-19 vaccine for India, UNICEF
✔️ Aurobindo Pharma Q3 net up 17% at 836 crore
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
-: Stock News :- AUROPHARMA 29-11-2020 To 31-05-2021
✔️ Aurobindo Pharma expects to commercialise Covid-19 vaccine facility by May
✔️ Aurobindo Pharma To Make,Sell COVAXX's Covid-19 Vaccine for India, UNICEF
✔️ Aurobindo Pharma enters licensing pact with US biotech COVAXX for manufacture, sale of COVID-19 vaccine
✔️ Aurobindo, COVAXX ink deal to develop, commercialise Covid-19 vaccine for India, UNICEF
✔️ Aurobindo Pharma Q3 net up 17% at 836 crore
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
-: Stock News :- AUROPHARMA 18-11-2020 To 31-05-2021
✔️ Accumulate Aurobindo Pharma; target of Rs 921: Prabhudas Lilladher
✔️ Aurobindo Pharma To Make,Sell COVAXX's Covid-19 Vaccine for India, UNICEF
✔️ Aurobindo Pharma enters licensing pact with US biotech COVAXX for manufacture, sale of COVID-19 vaccine
✔️ Aurobindo, COVAXX ink deal to develop, commercialise Covid-19 vaccine for India, UNICEF
✔️ Aurobindo Pharma Q3 net up 17% at 836 crore
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
-: Stock News :- AUROPHARMA 17-11-2020 To 31-05-2021
✔️ Buy Aurobindo Pharma; target of Rs 1025: ICICI Direct
✔️ Aurobindo Pharma To Make,Sell COVAXX's Covid-19 Vaccine for India, UNICEF
✔️ Aurobindo Pharma enters licensing pact with US biotech COVAXX for manufacture, sale of COVID-19 vaccine
✔️ Aurobindo, COVAXX ink deal to develop, commercialise Covid-19 vaccine for India, UNICEF
✔️ Aurobindo Pharma Q3 net up 17% at 836 crore
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
-: Stock News :- AUROPHARMA 12-11-2020 To 31-05-2021
✔️ Aurobindo Pharma rallies 6% as Q2 net profit rises 26% YoY to Rs 805.65 cr
✔️ Aurobindo Pharma shares up 4% after Q2 PAT rises 26% YoY
✔️ Aurobindo Pharma Q2 net up 26% at 806 crore
✔️ Aurobindo Pharma Q2 profit jumps 26% to Rs 805.6 crore; US business grows 12.5%
✔️ Aurobindo Pharma Q3 net up 17% at 836 crore
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
-: Stock News :- AUROPHARMA 06-11-2020 To 31-05-2021
✔️ Coal mine auction: Aurobindo Reality and Infra wins block in Jharkhand
✔️ Aurobindo Pharma shares up 4% after Q2 PAT rises 26% YoY
✔️ Aurobindo Pharma Q2 net up 26% at 806 crore
✔️ Aurobindo Pharma Q2 profit jumps 26% to Rs 805.6 crore; US business grows 12.5%
✔️ Aurobindo Pharma Q3 net up 17% at 836 crore
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
-: Stock News :- AUROPHARMA 28-10-2020 To 31-05-2021
✔️ Buy Aurobindo Pharma; target of Rs 985: Motilal Oswal
✔️ Aurobindo Pharma shares up 4% after Q2 PAT rises 26% YoY
✔️ Aurobindo Pharma Q2 net up 26% at 806 crore
✔️ Aurobindo Pharma Q2 profit jumps 26% to Rs 805.6 crore; US business grows 12.5%
✔️ Aurobindo Pharma Q3 net up 17% at 836 crore
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
-: Stock News :- AUROPHARMA 27-10-2020 To 26-10-2020
✔️ Buy Aurobindo Pharma; target of Rs 1025: ICICI Direct
✔️ Top headlines: Aurobindo Pharma to sell Natrol; Navratri drives car sales
✔️ Aurobindo Pharma to sell US-based Natrol for about Rs 4,048 crore
✔️ Divestment of US subsidiary to leave Aurobindo Pharma cash positive
✔️ Aurobindo Pharma inks pact to sell US-based unit for USD 550 mn; shares surge nearly 4%
✔️ Aurobindo Pharma share price rises 4% as subsidiary sells business assets
✔️ Aurobindo to sell US unit to New Mountain Capital for $550 million
-: Stock News :- AUROPHARMA 22-10-2020 To 26-10-2020
✔️ Aurobindo Pharma gets USFDA nod for generic pain killer
✔️ Aurobindo Pharma tumbles over 3% after USFDA warning letter to subsidiary
✔️ Aurobindo Pharma gets USFDA nod for pain treatment injection Acetaminophen
✔️ Divestment of US subsidiary to leave Aurobindo Pharma cash positive
✔️ Aurobindo Pharma inks pact to sell US-based unit for USD 550 mn; shares surge nearly 4%
✔️ Aurobindo Pharma share price rises 4% as subsidiary sells business assets
✔️ Aurobindo to sell US unit to New Mountain Capital for $550 million
-: Stock News :- AUROPHARMA 05-10-2020 To 26-10-2020
✔️ Aurobindo Pharma: Multiple growth triggers to improve Street sentiment
✔️ Aurobindo Pharma tumbles over 3% after USFDA warning letter to subsidiary
✔️ Aurobindo Pharma gets USFDA nod for pain treatment injection Acetaminophen
✔️ Divestment of US subsidiary to leave Aurobindo Pharma cash positive
✔️ Aurobindo Pharma inks pact to sell US-based unit for USD 550 mn; shares surge nearly 4%
✔️ Aurobindo Pharma share price rises 4% as subsidiary sells business assets
✔️ Aurobindo to sell US unit to New Mountain Capital for $550 million
-: Stock News :- AUROPHARMA 28-09-2020 To 26-10-2020
✔️ Buy Aurobindo Pharma; target of Rs 1030: Motilal Oswal
✔️ Aurobindo Pharma tumbles over 3% after USFDA warning letter to subsidiary
✔️ Aurobindo Pharma gets USFDA nod for pain treatment injection Acetaminophen
✔️ Divestment of US subsidiary to leave Aurobindo Pharma cash positive
✔️ Aurobindo Pharma inks pact to sell US-based unit for USD 550 mn; shares surge nearly 4%
✔️ Aurobindo Pharma share price rises 4% as subsidiary sells business assets
✔️ Aurobindo to sell US unit to New Mountain Capital for $550 million
-: Stock News :- AUROPHARMA 23-09-2020 To 26-10-2020
✔️ Buy Aurobindo Pharma; target of Rs 975: Sharekhan
✔️ Aurobindo Pharma tumbles over 3% after USFDA warning letter to subsidiary
✔️ Aurobindo Pharma gets USFDA nod for pain treatment injection Acetaminophen
✔️ Divestment of US subsidiary to leave Aurobindo Pharma cash positive
✔️ Aurobindo Pharma inks pact to sell US-based unit for USD 550 mn; shares surge nearly 4%
✔️ Aurobindo Pharma share price rises 4% as subsidiary sells business assets
✔️ Aurobindo to sell US unit to New Mountain Capital for $550 million
-: Stock News :- AUROPHARMA 16-09-2020 To 15-09-2020
✔️ Aurobindo Pharma: Shot in the arm for Covid vaccine development programme
✔️ MARKET LIVE: Indices likely to open lower; Aurobindo Pharma in focus
✔️ CSIR collaborates with Aurobindo Pharma to develop Covid-19 vaccines
✔️ Aurobindo gears up for multiple Covid-19 vaccines, ties up with CSIR
✔️ Aurobindo Pharma ties up with BIRAC to develop COVID-19 vaccine
✔️ Aurobindo Pharma ties up with BIRAC to develop coronavirus vaccine
✔️ DBT-BIRAC to support Aurobindo Pharma in vaccine development
-: Stock News :- AUROPHARMA 19-08-2020 To 15-09-2020
✔️ Buy Aurobindo Pharma; target of Rs 1027: KR Choksey
✔️ MARKET LIVE: Indices likely to open lower; Aurobindo Pharma in focus
✔️ CSIR collaborates with Aurobindo Pharma to develop Covid-19 vaccines
✔️ Aurobindo gears up for multiple Covid-19 vaccines, ties up with CSIR
✔️ Aurobindo Pharma ties up with BIRAC to develop COVID-19 vaccine
✔️ Aurobindo Pharma ties up with BIRAC to develop coronavirus vaccine
✔️ DBT-BIRAC to support Aurobindo Pharma in vaccine development
-: Stock News :- AUROPHARMA 14-08-2020 To 15-09-2020
✔️ Covid-19 vaccine: Aurobindo expects phase-I, II trials by end of 2020
✔️ MARKET LIVE: Indices likely to open lower; Aurobindo Pharma in focus
✔️ CSIR collaborates with Aurobindo Pharma to develop Covid-19 vaccines
✔️ Aurobindo gears up for multiple Covid-19 vaccines, ties up with CSIR
✔️ Aurobindo Pharma ties up with BIRAC to develop COVID-19 vaccine
✔️ Aurobindo Pharma ties up with BIRAC to develop coronavirus vaccine
✔️ DBT-BIRAC to support Aurobindo Pharma in vaccine development
-: Stock News :- AUROPHARMA 13-08-2020 To 12-08-2020
✔️ Strong US portfolio to drive revenue growth for Aurobindo Pharma
✔️ Aurobindo Pharma declines 4% despite 23% YoY jump in June quarter profit
✔️ Aurobindo Pharma shares fall 3% despite a 22% jump in Q1 profit
✔️ Aurobindo Pharma Q1 net up 23% at 781 cr
✔️ Stocks to watch: Aurobindo Pharma, Indiabulls Group counters, Hero Moto
✔️ Aurobindo Pharma Q1 results: Net profit up 23% to Rs 781 cr
✔️ Aurobindo Pharma Q1 profit jumps 23% to Rs 781 crore
-: Stock News :- AUROPHARMA 11-08-2020 To 12-08-2020
✔️ Poet Rahat Indori dies of cardiac arrest in Indore
✔️ Aurobindo Pharma declines 4% despite 23% YoY jump in June quarter profit
✔️ Aurobindo Pharma shares fall 3% despite a 22% jump in Q1 profit
✔️ Aurobindo Pharma Q1 net up 23% at 781 cr
✔️ Stocks to watch: Aurobindo Pharma, Indiabulls Group counters, Hero Moto
✔️ Aurobindo Pharma Q1 results: Net profit up 23% to Rs 781 cr
✔️ Aurobindo Pharma Q1 profit jumps 23% to Rs 781 crore
-: Stock News :- AUROPHARMA 08-08-2020 To 12-08-2020
✔️ Aurobindo Pharma enters Covid-19 vaccine race
✔️ Aurobindo Pharma declines 4% despite 23% YoY jump in June quarter profit
✔️ Aurobindo Pharma shares fall 3% despite a 22% jump in Q1 profit
✔️ Aurobindo Pharma Q1 net up 23% at 781 cr
✔️ Stocks to watch: Aurobindo Pharma, Indiabulls Group counters, Hero Moto
✔️ Aurobindo Pharma Q1 results: Net profit up 23% to Rs 781 cr
✔️ Aurobindo Pharma Q1 profit jumps 23% to Rs 781 crore
-: Stock News :- AUROPHARMA 07-08-2020 To 12-08-2020
✔️ COVID-19 pandemic: Aurobindo Pharma developing vaccine; gets shortlisted for BIRAC funding
✔️ Aurobindo Pharma working on COVID-19 vaccine; shortlisted for BIRAC funding
✔️ Aurobindo Pharma shares fall 3% despite a 22% jump in Q1 profit
✔️ Aurobindo Pharma Q1 net up 23% at 781 cr
✔️ Stocks to watch: Aurobindo Pharma, Indiabulls Group counters, Hero Moto
✔️ Aurobindo Pharma Q1 results: Net profit up 23% to Rs 781 cr
✔️ Aurobindo Pharma Q1 profit jumps 23% to Rs 781 crore
-: Stock News :- AUROPHARMA 09-07-2020 To 12-08-2020
✔️ Aurobindo Pharma share price at 52-week high on US FDA nod to blood pressure drug
✔️ Aurobindo Pharma working on COVID-19 vaccine; shortlisted for BIRAC funding
✔️ Aurobindo Pharma shares fall 3% despite a 22% jump in Q1 profit
✔️ Aurobindo Pharma Q1 net up 23% at 781 cr
✔️ Stocks to watch: Aurobindo Pharma, Indiabulls Group counters, Hero Moto
✔️ Aurobindo Pharma Q1 results: Net profit up 23% to Rs 781 cr
✔️ Aurobindo Pharma Q1 profit jumps 23% to Rs 781 crore
-: Stock News :- AUROPHARMA 22-06-2020 To 12-08-2020
✔️ Aurobindo Pharma plans to launch 50-60 products in US in FY21
✔️ Despite political tensions, Aurobindo Pharma bullish on business in China
✔️ Aurobindo Pharma shares fall 3% despite a 22% jump in Q1 profit
✔️ Aurobindo Pharma Q1 net up 23% at 781 cr
✔️ Stocks to watch: Aurobindo Pharma, Indiabulls Group counters, Hero Moto
✔️ Aurobindo Pharma Q1 results: Net profit up 23% to Rs 781 cr
✔️ Aurobindo Pharma Q1 profit jumps 23% to Rs 781 crore
-: Stock News :- AUROPHARMA 07-06-2020 To 12-08-2020
✔️ Buy Aurobindo Pharma; target of Rs 880: Motilal Oswal
✔️ Hold Aurobindo Pharma target of Rs 840: Sharekhan
✔️ Aurobindo Pharma shares fall 3% despite a 22% jump in Q1 profit
✔️ Aurobindo Pharma Q1 net up 23% at 781 cr
✔️ Stocks to watch: Aurobindo Pharma, Indiabulls Group counters, Hero Moto
✔️ Aurobindo Pharma Q1 results: Net profit up 23% to Rs 781 cr
✔️ Aurobindo Pharma Q1 profit jumps 23% to Rs 781 crore
-: Stock News :- AUROPHARMA 06-06-2020 To 12-08-2020
✔️ Aurobindo Pharma likely to become debt-free by FY22: Key highlights of concall
✔️ Hold Aurobindo Pharma target of Rs 840: Sharekhan
✔️ Aurobindo Pharma shares fall 3% despite a 22% jump in Q1 profit
✔️ Aurobindo Pharma Q1 net up 23% at 781 cr
✔️ Stocks to watch: Aurobindo Pharma, Indiabulls Group counters, Hero Moto
✔️ Aurobindo Pharma Q1 results: Net profit up 23% to Rs 781 cr
✔️ Aurobindo Pharma Q1 profit jumps 23% to Rs 781 crore
-: Stock News :- AUROPHARMA 05-06-2020 To 12-08-2020
✔️ Aurobindo: Traction in complex generics is vital to its health
✔️ Buy Aurobindo Pharma; target of Rs 870: ICICI Securities
✔️ FDA issues Form 483 with 9 observations to Aurobindo Pharma's USA facility
✔️ Aurobindo Pharma Q1 net up 23% at 781 cr
✔️ Stocks to watch: Aurobindo Pharma, Indiabulls Group counters, Hero Moto
✔️ Aurobindo Pharma Q1 results: Net profit up 23% to Rs 781 cr
✔️ Aurobindo Pharma Q1 profit jumps 23% to Rs 781 crore
-: Stock News :- AUROPHARMA 04-06-2020 To 03-06-2020
✔️ Aurobindo Pharm Standalone March 2020 Net Sales at Rs 3,620.32 crore, up 10.36% Y-o-Y
✔️ Aurobindo's US manufacturing facility gets inspectional observations
✔️ Aurobindo Pharma shares rally after robust quarterly earnings
✔️ Aurobindo Pharma's Q4 earnings ahead of Street; launches key to future growth
✔️ Aurobindo Pharma share price hits 52-week high on better Q4 numbers; Credit Suisse gives target of Rs 665
✔️ Aurobindo Pharma gains 5%, hits 52-week high as Q4 net profit jumps 45% YoY
✔️ Aurobindo Pharma Q4 net up 45% at 850 cr
✔️ Aurobindo Pharma Q4 PBT rises 32% to Rs1077.51 cr over higher revenue
✔️ Aurobindo Pharma's net jumps by 45% to Rs 850 crore in Q4
✔️ Aurobindo Pharma FY20 net profit rises 20% to Rs 2,831 crore
✔️ Aurobindo Pharma Q4 profit may report double-digit growth led by key geographies
-: Stock News :- AUROPHARMA 29-05-2020 To 03-06-2020
✔️ Aurobindo Pharma to invest Rs 1,500 cr in Andhra Pradesh
✔️ Aurobindo's US manufacturing facility gets inspectional observations
✔️ Aurobindo Pharma shares rally after robust quarterly earnings
✔️ Aurobindo Pharma's Q4 earnings ahead of Street; launches key to future growth
✔️ Aurobindo Pharma share price hits 52-week high on better Q4 numbers; Credit Suisse gives target of Rs 665
✔️ Aurobindo Pharma gains 5%, hits 52-week high as Q4 net profit jumps 45% YoY
✔️ Aurobindo Pharma Q4 net up 45% at 850 cr
✔️ Aurobindo Pharma Q4 PBT rises 32% to Rs1077.51 cr over higher revenue
✔️ Aurobindo Pharma's net jumps by 45% to Rs 850 crore in Q4
✔️ Aurobindo Pharma FY20 net profit rises 20% to Rs 2,831 crore
✔️ Aurobindo Pharma Q4 profit may report double-digit growth led by key geographies
-: Stock News :- AUROPHARMA 26-05-2020 To 03-06-2020
✔️ Pharma, chemical stocks lead under lockdown, Aurobindo is top performer
✔️ Aurobindo's US manufacturing facility gets inspectional observations
✔️ Aurobindo Pharma shares rally after robust quarterly earnings
✔️ Aurobindo Pharma's Q4 earnings ahead of Street; launches key to future growth
✔️ Aurobindo Pharma share price hits 52-week high on better Q4 numbers; Credit Suisse gives target of Rs 665
✔️ Aurobindo Pharma gains 5%, hits 52-week high as Q4 net profit jumps 45% YoY
✔️ Aurobindo Pharma Q4 net up 45% at 850 cr
✔️ Aurobindo Pharma Q4 PBT rises 32% to Rs1077.51 cr over higher revenue
✔️ Aurobindo Pharma's net jumps by 45% to Rs 850 crore in Q4
✔️ Aurobindo Pharma FY20 net profit rises 20% to Rs 2,831 crore
✔️ Aurobindo Pharma Q4 profit may report double-digit growth led by key geographies
-: Stock News :- AUROPHARMA 15-05-2020 To 03-06-2020
✔️ Buy Aurobindo Pharma; target of Rs 790: HDFC Securities
✔️ Aurobindo's US manufacturing facility gets inspectional observations
✔️ Aurobindo Pharma shares rally after robust quarterly earnings
✔️ Aurobindo Pharma's Q4 earnings ahead of Street; launches key to future growth
✔️ Aurobindo Pharma share price hits 52-week high on better Q4 numbers; Credit Suisse gives target of Rs 665
✔️ Aurobindo Pharma gains 5%, hits 52-week high as Q4 net profit jumps 45% YoY
✔️ Aurobindo Pharma Q4 net up 45% at 850 cr
✔️ Aurobindo Pharma Q4 PBT rises 32% to Rs1077.51 cr over higher revenue
✔️ Aurobindo Pharma's net jumps by 45% to Rs 850 crore in Q4
✔️ Aurobindo Pharma FY20 net profit rises 20% to Rs 2,831 crore
✔️ Aurobindo Pharma Q4 profit may report double-digit growth led by key geographies
-: Stock News :- AUROPHARMA 07-05-2020 To 03-06-2020
✔️ Famotidine shortage in US may benefit Indian pharmaceutical companies
✔️ Aurobindo's US manufacturing facility gets inspectional observations
✔️ Aurobindo Pharma shares rally after robust quarterly earnings
✔️ Aurobindo Pharma's Q4 earnings ahead of Street; launches key to future growth
✔️ Aurobindo Pharma share price hits 52-week high on better Q4 numbers; Credit Suisse gives target of Rs 665
✔️ Aurobindo Pharma gains 5%, hits 52-week high as Q4 net profit jumps 45% YoY
✔️ Aurobindo Pharma Q4 net up 45% at 850 cr
✔️ Aurobindo Pharma Q4 PBT rises 32% to Rs1077.51 cr over higher revenue
✔️ Aurobindo Pharma's net jumps by 45% to Rs 850 crore in Q4
✔️ Aurobindo Pharma FY20 net profit rises 20% to Rs 2,831 crore
✔️ Aurobindo Pharma Q4 profit may report double-digit growth led by key geographies
-: Stock News :- AUROPHARMA 22-04-2020 To 03-06-2020
✔️ Aurobindo Pharma shares jump 3% after Credit Suisse upgrade, raises target to Rs 665/sh
✔️ Aurobindo's US manufacturing facility gets inspectional observations
✔️ Aurobindo Pharma shares rally after robust quarterly earnings
✔️ Aurobindo Pharma's Q4 earnings ahead of Street; launches key to future growth
✔️ Aurobindo Pharma share price hits 52-week high on better Q4 numbers; Credit Suisse gives target of Rs 665
✔️ Aurobindo Pharma gains 5%, hits 52-week high as Q4 net profit jumps 45% YoY
✔️ Aurobindo Pharma Q4 net up 45% at 850 cr
✔️ Aurobindo Pharma Q4 PBT rises 32% to Rs1077.51 cr over higher revenue
✔️ Aurobindo Pharma's net jumps by 45% to Rs 850 crore in Q4
✔️ Aurobindo Pharma FY20 net profit rises 20% to Rs 2,831 crore
✔️ Aurobindo Pharma Q4 profit may report double-digit growth led by key geographies
-: Stock News :- AUROPHARMA 21-04-2020 To 03-06-2020
✔️ Aurobindo shines; 280 stocks hit upper circuits
✔️ Aurobindo Pharma gets VAI classification from US regulator for Hyderabad unit
✔️ US FDA clears Aurobindo Pharma Unit IV, reverts classification to VAI
✔️ USFDA observation lifts Aurobindo Pharma
✔️ Aurobindo Pharma share price zooms 10% after FDA's VAI status for Hyderabad unit
✔️ Aurobindo Pharma gains 15% as USFDA grants VAI to Unit IV facility
✔️ Aurobindo Pharma Q4 net up 45% at 850 cr
✔️ Aurobindo Pharma Q4 PBT rises 32% to Rs1077.51 cr over higher revenue
✔️ Aurobindo Pharma's net jumps by 45% to Rs 850 crore in Q4
✔️ Aurobindo Pharma FY20 net profit rises 20% to Rs 2,831 crore
✔️ Aurobindo Pharma Q4 profit may report double-digit growth led by key geographies
-: Stock News :- AUROPHARMA 09-04-2020 To 03-06-2020
✔️ Aurobindo Pharma weathers scrapping of Sandoz deal
✔️ An Indore physician could be the first frontline worker to die of Covid-19
✔️ Aurobindo Pharma share price jumps 6% on USFDA nod for antidepressant
✔️ USFDA observation lifts Aurobindo Pharma
✔️ Aurobindo Pharma share price zooms 10% after FDA's VAI status for Hyderabad unit
✔️ Aurobindo Pharma gains 15% as USFDA grants VAI to Unit IV facility
✔️ Aurobindo Pharma Q4 net up 45% at 850 cr
✔️ Aurobindo Pharma Q4 PBT rises 32% to Rs1077.51 cr over higher revenue
✔️ Aurobindo Pharma's net jumps by 45% to Rs 850 crore in Q4
✔️ Aurobindo Pharma FY20 net profit rises 20% to Rs 2,831 crore
✔️ Aurobindo Pharma Q4 profit may report double-digit growth led by key geographies
-: Stock News :- AUROPHARMA 08-04-2020 To 03-06-2020
✔️ Aurobindo Pharma sued in US for hiding facts on cancer-causing agent
✔️ An Indore physician could be the first frontline worker to die of Covid-19
✔️ Aurobindo Pharma share price jumps 6% on USFDA nod for antidepressant
✔️ USFDA observation lifts Aurobindo Pharma
✔️ Aurobindo Pharma share price zooms 10% after FDA's VAI status for Hyderabad unit
✔️ Aurobindo Pharma gains 15% as USFDA grants VAI to Unit IV facility
✔️ Aurobindo Pharma Q4 net up 45% at 850 cr
✔️ Aurobindo Pharma Q4 PBT rises 32% to Rs1077.51 cr over higher revenue
✔️ Aurobindo Pharma's net jumps by 45% to Rs 850 crore in Q4
✔️ Aurobindo Pharma FY20 net profit rises 20% to Rs 2,831 crore
✔️ Aurobindo Pharma Q4 profit may report double-digit growth led by key geographies
-: Stock News :- AUROPHARMA 03-04-2020 To 03-06-2020
✔️ Aurobindo Pharma share price gains 4% despite calling off deal with Sandoz
✔️ Aurobindo Pharma, Sandoz Inc call off $900 million deal
✔️ Aurobindo Pharma calls off acquisition deal with Sandoz
✔️ Aurobindo terminates $900-million Sandoz product acquistion deal
✔️ Aurobindo, Sandoz call off USD 900 mn deal
✔️ Aurobindo calls off acquisition deal with Sandoz; scrip down
✔️ Aurobindo Pharma Q4 net up 45% at 850 cr
✔️ Aurobindo Pharma Q4 PBT rises 32% to Rs1077.51 cr over higher revenue
✔️ Aurobindo Pharma's net jumps by 45% to Rs 850 crore in Q4
✔️ Aurobindo Pharma FY20 net profit rises 20% to Rs 2,831 crore
✔️ Aurobindo Pharma Q4 profit may report double-digit growth led by key geographies
-: Stock News :- AUROPHARMA 27-03-2020 To 03-06-2020
✔️ Aurobindo Pharma gains 12% after USFDA issued EIR for Hyderabad facility
✔️ Aurobindo Pharma share price jumps 11% after US FDA nod for muscle relaxant
✔️ Aurobindo Pharma calls off acquisition deal with Sandoz
✔️ Aurobindo terminates $900-million Sandoz product acquistion deal
✔️ Aurobindo, Sandoz call off USD 900 mn deal
✔️ Aurobindo calls off acquisition deal with Sandoz; scrip down
✔️ Aurobindo Pharma Q4 net up 45% at 850 cr
✔️ Aurobindo Pharma Q4 PBT rises 32% to Rs1077.51 cr over higher revenue
✔️ Aurobindo Pharma's net jumps by 45% to Rs 850 crore in Q4
✔️ Aurobindo Pharma FY20 net profit rises 20% to Rs 2,831 crore
✔️ Aurobindo Pharma Q4 profit may report double-digit growth led by key geographies
-: Stock News :- AUROPHARMA 26-02-2020 To 03-06-2020
✔️ Aurobindo Pharma gains 3% on red flags from USFDA
✔️ Avoid Aurobindo Pharma for now: Hemang Jani
✔️ Aurobindo Pharma calls off acquisition deal with Sandoz
✔️ Aurobindo terminates $900-million Sandoz product acquistion deal
✔️ Aurobindo, Sandoz call off USD 900 mn deal
✔️ Aurobindo calls off acquisition deal with Sandoz; scrip down
✔️ Aurobindo Pharma Q4 net up 45% at 850 cr
✔️ Aurobindo Pharma Q4 PBT rises 32% to Rs1077.51 cr over higher revenue
✔️ Aurobindo Pharma's net jumps by 45% to Rs 850 crore in Q4
✔️ Aurobindo Pharma FY20 net profit rises 20% to Rs 2,831 crore
✔️ Aurobindo Pharma Q4 profit may report double-digit growth led by key geographies
-: Stock News :- AUROPHARMA 24-02-2020 To 03-06-2020
✔️ Aurobindo Pharma share price tanks 18% after USFDA revokes VAI status for Unit 4
✔️ Aurobindo Pharma slips 17% as USFDA revokes VAI status for Unit-IV
✔️ Aurobindo could face pressure after USFDA action
✔️ Aurobindo could face pressure after USFDA action
✔️ Aurobindo, Sandoz call off USD 900 mn deal
✔️ Aurobindo calls off acquisition deal with Sandoz; scrip down
✔️ Aurobindo Pharma Q4 net up 45% at 850 cr
✔️ Aurobindo Pharma Q4 PBT rises 32% to Rs1077.51 cr over higher revenue
✔️ Aurobindo Pharma's net jumps by 45% to Rs 850 crore in Q4
✔️ Aurobindo Pharma FY20 net profit rises 20% to Rs 2,831 crore
✔️ Aurobindo Pharma Q4 profit may report double-digit growth led by key geographies
-: Stock News :- AUROPHARMA 22-02-2020 To 03-06-2020
✔️ USFDA reopens investigation of Aurobindo's unit 4 facility
✔️ USFDA rescinds VAI status for Aurobindo Pharma's Hyderabad unit
✔️ Aurobindo could face pressure after USFDA action
✔️ Aurobindo could face pressure after USFDA action
✔️ Aurobindo, Sandoz call off USD 900 mn deal
✔️ Aurobindo calls off acquisition deal with Sandoz; scrip down
✔️ Aurobindo Pharma Q4 net up 45% at 850 cr
✔️ Aurobindo Pharma Q4 PBT rises 32% to Rs1077.51 cr over higher revenue
✔️ Aurobindo Pharma's net jumps by 45% to Rs 850 crore in Q4
✔️ Aurobindo Pharma FY20 net profit rises 20% to Rs 2,831 crore
✔️ Aurobindo Pharma Q4 profit may report double-digit growth led by key geographies
-: Stock News :- AUROPHARMA 20-02-2020 To 03-06-2020
✔️ Aurobindo Pharma share price gains 2% as Citi maintains buy, target Rs 820
✔️ USFDA nod to Unit IV a breather for Aurobindo Pharma; share price up 20.4%
✔️ Aurobindo Pharma share price climbs over 18% on EIR from USFDA
✔️ Aurobindo Pharma surges 18% on receiving EIR
✔️ Aurobindo Pharma gets US FDA inspection report for Pashamylaram unit
✔️ Aurobindo Pharma share price gains 19% on EIR from USFDA
✔️ Aurobindo Pharma surges 19% as Unit IV receives EIR with VAI staus from FDA
✔️ Aurobindo Pharma Q4 PBT rises 32% to Rs1077.51 cr over higher revenue
✔️ Aurobindo Pharma's net jumps by 45% to Rs 850 crore in Q4
✔️ Aurobindo Pharma FY20 net profit rises 20% to Rs 2,831 crore
✔️ Aurobindo Pharma Q4 profit may report double-digit growth led by key geographies
-: Stock News :- AUROPHARMA 19-08-2022 To 19-08-2022
✔️ Accumulate Aurobindo Pharma; target of Rs 626: KR Choksey
-: Stock News :- AUROPHARMA 17-08-2022 To 17-08-2022
✔️ Accumulate Aurobindo Pharma; target of Rs 635: Prabhudas Lilladher
✔️ Hold Aurobindo Pharma; target of Rs 640: Sharekhan
-: Stock News :- AUROPHARMA 16-08-2022 To 16-08-2022
✔️ USFDA approves Aurobindo Pharma owned Eugia's generic Vasopressin injection
✔️ Aurobindo Pharma arm gets final USFDA nod for Vasopressin injection
-: Stock News :- AUROPHARMA 11-08-2022 To 11-08-2022
✔️ Aurobindo Pharma Q1 net profit down by 32% to Rs 520.5 cr; revenue up 9.4%
✔️ Aurobindo Pharma's Q1 net down 32% at 520 cr
✔️ Aurobindo Pharma's Q1 net down 32% at 520 cr
-: Stock News :- AUROPHARMA 02-08-2022 To 11-08-2022
✔️ Aurobindo Pharma's Andhra unit gets Form 483 with 3 USFDA observations
✔️ Aurobindo Pharma's Q1 net down 32% at 520 cr
✔️ Aurobindo Pharma's Q1 net down 32% at 520 cr
-: Stock News :- AUROPHARMA 10-07-2022 To 11-08-2022
✔️ Aurobindo Pharma to develop complex products, expand global footprint
✔️ Aurobindo Pharma's Q1 net down 32% at 520 cr
✔️ Aurobindo Pharma's Q1 net down 32% at 520 cr
-: Stock News :- AUROPHARMA 09-06-2022 To 11-08-2022
✔️ Aurobindo Pharma approves fourth interim dividend of 4.50 per share
✔️ Aurobindo Pharma's Q1 net down 32% at 520 cr
✔️ Aurobindo Pharma's Q1 net down 32% at 520 cr
-: Stock News :- AUROPHARMA 07-06-2022 To 11-08-2022
✔️ Eugia Pharma gets USFDA nod for prostate cancer drug
✔️ Aurobindo Pharma's Q1 net down 32% at 520 cr
✔️ Aurobindo Pharma's Q1 net down 32% at 520 cr
-: Stock News :- AUROPHARMA 03-06-2022 To 11-08-2022
✔️ Near-term growth issues and cost pressure could impact Aurobindo Pharma
✔️ Aurobindo Pharma's Q1 net down 32% at 520 cr
✔️ Aurobindo Pharma's Q1 net down 32% at 520 cr
-: Stock News :- AUROPHARMA 01-06-2022 To 11-08-2022
✔️ Near-term growth and cost challenges to weigh on Aurobindo Pharma stock
✔️ Aurobindo Pharma's Q1 net down 32% at 520 cr
✔️ Aurobindo Pharma's Q1 net down 32% at 520 cr
-: Stock News :- AUROPHARMA 01-09-2022 To 01-09-2022
✔️ Aurobindo Pharma's arm to invest around Rs 300 cr for capacity expansion
-: Stock News :- AUROPHARMA 29-08-2022 To 29-08-2022
✔️ Anand Rathi bullish on this pharma stock, sees strong upside in 3 months
-: Stock News :- AUROPHARMA 22-10-2022 To 22-10-2022
✔️ Tech Query: Where can Aurobindo Pharma find a bottom?
-: Stock News :- AUROPHARMA 12-11-2022 To 12-11-2022
✔️ Aurobindo Pharma's Q2 net down 41% at 409 cr
✔️ Aurobindo Pharma Q2 net down 41% to Rs 409 cr, revenue dips to Rs 5,739 cr
✔️ Aurobindo Pharma Q2 results: Net profit drops 41% to Rs 409 crore
✔️ Aurobindo Pharma Q2 net drops 41% to Rs 409 crore
-: Stock News :- AUROPHARMA 11-11-2022 To 12-11-2022
✔️ Aurobindo Pharma Shares Gain 3%, A Day After Hitting A 52-Week Low
✔️ Aurobindo Pharma Stock Falls Nearly 7% In Early Trade After Q2 Results
✔️ Aurobindo Pharma slips 7%, hits over 2-year low on weak Q2 results
✔️ Bottomline | The worrisome case of Aurobindo Pharma
✔️ Aurobindo Pharma's Second Quarter Net Profit Falls 41% To Rs 409 Crore
✔️ Aurobindo Pharma's Q2 net down 41% at 409 cr
✔️ Aurobindo Pharma Q2 net down 41% to Rs 409 cr, revenue dips to Rs 5,739 cr
✔️ Aurobindo Pharma Q2 results: Net profit drops 41% to Rs 409 crore
✔️ Aurobindo Pharma Q2 net drops 41% to Rs 409 crore
-: Stock News :- AUROPHARMA 11-11-2022 To 10-11-2022
✔️ Aurobindo Pharma gains 3% in early trade a day after touching a 52-week low
✔️ Delhi excise policy case: ED arrests 2 pvt company executives
✔️ Delhi excise scam resulted in 2,631-cr loss to public exchequer: ED
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ 'Not in any way connected with operations': Aurobindo Pharma on arrest of its promoter by ED
✔️ Delhi liquor scam: Will disclose details after internal probe, says Aurobindo Pharma after promoter's arrest
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 08-11-2022 To 10-11-2022
✔️ Aurobindo units recall products in US market for manufacturing issues
✔️ Aurobindo Pharma units recall products in US market for manufacturing issues
✔️ Delhi excise scam resulted in 2,631-cr loss to public exchequer: ED
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ 'Not in any way connected with operations': Aurobindo Pharma on arrest of its promoter by ED
✔️ Delhi liquor scam: Will disclose details after internal probe, says Aurobindo Pharma after promoter's arrest
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 22-10-2022 To 10-11-2022
✔️ Tech Query: Where can Aurobindo Pharma find a bottom?
✔️ Aurobindo Pharma units recall products in US market for manufacturing issues
✔️ Delhi excise scam resulted in 2,631-cr loss to public exchequer: ED
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ 'Not in any way connected with operations': Aurobindo Pharma on arrest of its promoter by ED
✔️ Delhi liquor scam: Will disclose details after internal probe, says Aurobindo Pharma after promoter's arrest
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 01-09-2022 To 10-11-2022
✔️ Aurobindo Pharma's arm to invest around Rs 300 cr for capacity expansion
✔️ Aurobindo Pharma units recall products in US market for manufacturing issues
✔️ Delhi excise scam resulted in 2,631-cr loss to public exchequer: ED
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ 'Not in any way connected with operations': Aurobindo Pharma on arrest of its promoter by ED
✔️ Delhi liquor scam: Will disclose details after internal probe, says Aurobindo Pharma after promoter's arrest
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 29-08-2022 To 10-11-2022
✔️ Anand Rathi bullish on this pharma stock, sees strong upside in 3 months
✔️ Aurobindo Pharma units recall products in US market for manufacturing issues
✔️ Delhi excise scam resulted in 2,631-cr loss to public exchequer: ED
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ 'Not in any way connected with operations': Aurobindo Pharma on arrest of its promoter by ED
✔️ Delhi liquor scam: Will disclose details after internal probe, says Aurobindo Pharma after promoter's arrest
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 19-08-2022 To 10-11-2022
✔️ Accumulate Aurobindo Pharma; target of Rs 626: KR Choksey
✔️ Aurobindo Pharma units recall products in US market for manufacturing issues
✔️ Delhi excise scam resulted in 2,631-cr loss to public exchequer: ED
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ 'Not in any way connected with operations': Aurobindo Pharma on arrest of its promoter by ED
✔️ Delhi liquor scam: Will disclose details after internal probe, says Aurobindo Pharma after promoter's arrest
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 17-08-2022 To 10-11-2022
✔️ Accumulate Aurobindo Pharma; target of Rs 635: Prabhudas Lilladher
✔️ Hold Aurobindo Pharma; target of Rs 640: Sharekhan
✔️ Delhi excise scam resulted in 2,631-cr loss to public exchequer: ED
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ 'Not in any way connected with operations': Aurobindo Pharma on arrest of its promoter by ED
✔️ Delhi liquor scam: Will disclose details after internal probe, says Aurobindo Pharma after promoter's arrest
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 16-08-2022 To 10-11-2022
✔️ USFDA approves Aurobindo Pharma owned Eugia's generic Vasopressin injection
✔️ Aurobindo Pharma arm gets final USFDA nod for Vasopressin injection
✔️ Delhi excise scam resulted in 2,631-cr loss to public exchequer: ED
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ 'Not in any way connected with operations': Aurobindo Pharma on arrest of its promoter by ED
✔️ Delhi liquor scam: Will disclose details after internal probe, says Aurobindo Pharma after promoter's arrest
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 11-08-2022 To 10-11-2022
✔️ Q1FY23 Quarterly Result Announced for Aurobindo Pharma Ltd.
✔️ Aurobindo Pharma's Q1 net down 32% at 520 cr
✔️ Aurobindo Pharma's Q1 net down 32% at 520 cr
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ 'Not in any way connected with operations': Aurobindo Pharma on arrest of its promoter by ED
✔️ Delhi liquor scam: Will disclose details after internal probe, says Aurobindo Pharma after promoter's arrest
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 02-08-2022 To 10-11-2022
✔️ Aurobindo Pharma's Andhra unit gets Form 483 with 3 USFDA observations
✔️ Aurobindo Pharma's Q1 net down 32% at 520 cr
✔️ Aurobindo Pharma's Q1 net down 32% at 520 cr
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ 'Not in any way connected with operations': Aurobindo Pharma on arrest of its promoter by ED
✔️ Delhi liquor scam: Will disclose details after internal probe, says Aurobindo Pharma after promoter's arrest
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 10-07-2022 To 10-11-2022
✔️ Aurobindo Pharma to develop complex products, expand global footprint
✔️ Aurobindo Pharma's Q1 net down 32% at 520 cr
✔️ Aurobindo Pharma's Q1 net down 32% at 520 cr
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ 'Not in any way connected with operations': Aurobindo Pharma on arrest of its promoter by ED
✔️ Delhi liquor scam: Will disclose details after internal probe, says Aurobindo Pharma after promoter's arrest
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 09-06-2022 To 10-11-2022
✔️ Aurobindo Pharma approves fourth interim dividend of 4.50 per share
✔️ Aurobindo Pharma's Q1 net down 32% at 520 cr
✔️ Aurobindo Pharma's Q1 net down 32% at 520 cr
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ 'Not in any way connected with operations': Aurobindo Pharma on arrest of its promoter by ED
✔️ Delhi liquor scam: Will disclose details after internal probe, says Aurobindo Pharma after promoter's arrest
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 07-06-2022 To 10-11-2022
✔️ Eugia Pharma gets USFDA nod for prostate cancer drug
✔️ Aurobindo Pharma's Q1 net down 32% at 520 cr
✔️ Aurobindo Pharma's Q1 net down 32% at 520 cr
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ 'Not in any way connected with operations': Aurobindo Pharma on arrest of its promoter by ED
✔️ Delhi liquor scam: Will disclose details after internal probe, says Aurobindo Pharma after promoter's arrest
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 03-06-2022 To 10-11-2022
✔️ Near-term growth issues and cost pressure could impact Aurobindo Pharma
✔️ Aurobindo Pharma's Q1 net down 32% at 520 cr
✔️ Aurobindo Pharma's Q1 net down 32% at 520 cr
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ 'Not in any way connected with operations': Aurobindo Pharma on arrest of its promoter by ED
✔️ Delhi liquor scam: Will disclose details after internal probe, says Aurobindo Pharma after promoter's arrest
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 01-06-2022 To 10-11-2022
✔️ Near-term growth and cost challenges to weigh on Aurobindo Pharma stock
✔️ Aurobindo Pharma's Q1 net down 32% at 520 cr
✔️ Aurobindo Pharma's Q1 net down 32% at 520 cr
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ 'Not in any way connected with operations': Aurobindo Pharma on arrest of its promoter by ED
✔️ Delhi liquor scam: Will disclose details after internal probe, says Aurobindo Pharma after promoter's arrest
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 30-05-2022 To 10-11-2022
✔️ Aurobindo Pharma Q4 net profit falls 28% to Rs 576 cr; revenue dips 3%
✔️ Aurobindo Pharma Q4 net down 28%
✔️ Aurobindo Pharma's Q4 net profit down 28%, revenue slips to Rs 5,809 crore
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ 'Not in any way connected with operations': Aurobindo Pharma on arrest of its promoter by ED
✔️ Delhi liquor scam: Will disclose details after internal probe, says Aurobindo Pharma after promoter's arrest
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 11-05-2022 To 10-11-2022
✔️ Aurobindo Pharma hits 52-week low after six observations from US
✔️ Aurobindo Pharma Q4 net down 28%
✔️ Aurobindo Pharma's Q4 net profit down 28%, revenue slips to Rs 5,809 crore
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ 'Not in any way connected with operations': Aurobindo Pharma on arrest of its promoter by ED
✔️ Delhi liquor scam: Will disclose details after internal probe, says Aurobindo Pharma after promoter's arrest
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 04-05-2022 To 10-11-2022
✔️ Aurobindo Pharma gets USFDA nod to market generic cancer drug Bortezomib
✔️ Aurobindo Pharma Q4 net down 28%
✔️ Aurobindo Pharma's Q4 net profit down 28%, revenue slips to Rs 5,809 crore
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ 'Not in any way connected with operations': Aurobindo Pharma on arrest of its promoter by ED
✔️ Delhi liquor scam: Will disclose details after internal probe, says Aurobindo Pharma after promoter's arrest
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 03-05-2022 To 10-11-2022
✔️ Aurobindo Pharma gets USFDA nod for generic cancer drug Bortezomib
✔️ Aurobindo Pharma Q4 net down 28%
✔️ Aurobindo Pharma's Q4 net profit down 28%, revenue slips to Rs 5,809 crore
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ 'Not in any way connected with operations': Aurobindo Pharma on arrest of its promoter by ED
✔️ Delhi liquor scam: Will disclose details after internal probe, says Aurobindo Pharma after promoter's arrest
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 14-04-2022 To 10-11-2022
✔️ Aurobindo Pharma Q4 PAT may dip 26.6% YoY to Rs 588.1 cr: Prabhudas Lilladher
✔️ Aurobindo Pharma Q4 net down 28%
✔️ Aurobindo Pharma's Q4 net profit down 28%, revenue slips to Rs 5,809 crore
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ 'Not in any way connected with operations': Aurobindo Pharma on arrest of its promoter by ED
✔️ Delhi liquor scam: Will disclose details after internal probe, says Aurobindo Pharma after promoter's arrest
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 28-03-2022 To 10-11-2022
✔️ Aurobindo Pharma acquires Veritaz' domestic business for Rs 171 cr
✔️ Aurobindo Pharma acquires Veritaz Healthcare for Rs 171 crore
✔️ Aurobindo Pharma buys domestic formulation business of Veritaz for 171 cr
✔️ Aurobindo Pharma acquires Veritaz formulation business for Rs 171 crore
✔️ 'Not in any way connected with operations': Aurobindo Pharma on arrest of its promoter by ED
✔️ Delhi liquor scam: Will disclose details after internal probe, says Aurobindo Pharma after promoter's arrest
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 17-02-2022 To 10-11-2022
✔️ Buy Aurobindo Pharma; target of Rs 875: Sharekhan
✔️ Aurobindo Pharma acquires Veritaz Healthcare for Rs 171 crore
✔️ Aurobindo Pharma buys domestic formulation business of Veritaz for 171 cr
✔️ Aurobindo Pharma acquires Veritaz formulation business for Rs 171 crore
✔️ 'Not in any way connected with operations': Aurobindo Pharma on arrest of its promoter by ED
✔️ Delhi liquor scam: Will disclose details after internal probe, says Aurobindo Pharma after promoter's arrest
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 15-02-2022 To 10-11-2022
✔️ Accumulate Aurobindo Pharma; target of Rs 759: Prabhudas Lilladher
✔️ Accumulate Aurobindo Pharma; target of Rs 756: KR Choksey
✔️ Aurobindo Pharma buys domestic formulation business of Veritaz for 171 cr
✔️ Aurobindo Pharma acquires Veritaz formulation business for Rs 171 crore
✔️ 'Not in any way connected with operations': Aurobindo Pharma on arrest of its promoter by ED
✔️ Delhi liquor scam: Will disclose details after internal probe, says Aurobindo Pharma after promoter's arrest
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 11-02-2022 To 10-11-2022
✔️ Will the Street reward Aurobindo Pharma's bet on domestic formulations?
✔️ Accumulate Aurobindo Pharma; target of Rs 756: KR Choksey
✔️ Aurobindo Pharma buys domestic formulation business of Veritaz for 171 cr
✔️ Aurobindo Pharma acquires Veritaz formulation business for Rs 171 crore
✔️ 'Not in any way connected with operations': Aurobindo Pharma on arrest of its promoter by ED
✔️ Delhi liquor scam: Will disclose details after internal probe, says Aurobindo Pharma after promoter's arrest
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 09-02-2022 To 10-11-2022
✔️ Q3FY22 Quarterly Result Announced for Aurobindo Pharma Ltd.
✔️ Accumulate Aurobindo Pharma; target of Rs 756: KR Choksey
✔️ Aurobindo Pharma buys domestic formulation business of Veritaz for 171 cr
✔️ Aurobindo Pharma acquires Veritaz formulation business for Rs 171 crore
✔️ 'Not in any way connected with operations': Aurobindo Pharma on arrest of its promoter by ED
✔️ Delhi liquor scam: Will disclose details after internal probe, says Aurobindo Pharma after promoter's arrest
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 27-01-2022 To 10-11-2022
✔️ USFDA pulls up Aurobindo Pharma for manufacturing lapses at API plant
✔️ USFDA pulls up Aurobindo Pharma for manufacturing lapses at API plant
✔️ Aurobindo Pharma buys domestic formulation business of Veritaz for 171 cr
✔️ Aurobindo Pharma acquires Veritaz formulation business for Rs 171 crore
✔️ 'Not in any way connected with operations': Aurobindo Pharma on arrest of its promoter by ED
✔️ Delhi liquor scam: Will disclose details after internal probe, says Aurobindo Pharma after promoter's arrest
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 14-01-2022 To 10-11-2022
✔️ Aurobindo Pharma down 5% on USFDA warning letter for Hyderabad unit
✔️ Aurobindo Pharma gets warning letter from USFDA for API facility
✔️ Aurobindo Pharma falls over 3% after bulk drug manufacturing unit receives warning letter from US
✔️ Aurobindo Pharma acquires Veritaz formulation business for Rs 171 crore
✔️ 'Not in any way connected with operations': Aurobindo Pharma on arrest of its promoter by ED
✔️ Delhi liquor scam: Will disclose details after internal probe, says Aurobindo Pharma after promoter's arrest
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 13-01-2022 To 10-11-2022
✔️ Aurobindo Pharma Q3 PAT may dip 73% YoY to Rs 795.3 cr: Prabhudas Lilladher
✔️ Aurobindo Pharma gets warning letter from USFDA for API facility
✔️ Aurobindo Pharma falls over 3% after bulk drug manufacturing unit receives warning letter from US
✔️ Aurobindo Pharma acquires Veritaz formulation business for Rs 171 crore
✔️ 'Not in any way connected with operations': Aurobindo Pharma on arrest of its promoter by ED
✔️ Delhi liquor scam: Will disclose details after internal probe, says Aurobindo Pharma after promoter's arrest
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 11-01-2022 To 10-11-2022
✔️ Aurobindo Pharma arm CuraTeQ expands scope of distribution pact with Orion
✔️ Aurobindo Pharma arm CuraTeQ expands scope of distribution pact with Orion
✔️ Aurobindo Pharma falls over 3% after bulk drug manufacturing unit receives warning letter from US
✔️ Aurobindo Pharma acquires Veritaz formulation business for Rs 171 crore
✔️ 'Not in any way connected with operations': Aurobindo Pharma on arrest of its promoter by ED
✔️ Delhi liquor scam: Will disclose details after internal probe, says Aurobindo Pharma after promoter's arrest
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 06-01-2022 To 10-11-2022
✔️ Aurobindo Pharma launches Molnupiravir at 50 per capsule
✔️ Aurobindo Pharma launches COVID-19 drug Molnupiravir in India
✔️ Aurobindo Pharma falls over 3% after bulk drug manufacturing unit receives warning letter from US
✔️ Aurobindo Pharma acquires Veritaz formulation business for Rs 171 crore
✔️ 'Not in any way connected with operations': Aurobindo Pharma on arrest of its promoter by ED
✔️ Delhi liquor scam: Will disclose details after internal probe, says Aurobindo Pharma after promoter's arrest
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 05-12-2021 To 10-11-2022
✔️ Aurobindo Pharma, Unichem Laboratories recall products in US market
✔️ Aurobindo Pharma launches COVID-19 drug Molnupiravir in India
✔️ Aurobindo Pharma falls over 3% after bulk drug manufacturing unit receives warning letter from US
✔️ Aurobindo Pharma acquires Veritaz formulation business for Rs 171 crore
✔️ 'Not in any way connected with operations': Aurobindo Pharma on arrest of its promoter by ED
✔️ Delhi liquor scam: Will disclose details after internal probe, says Aurobindo Pharma after promoter's arrest
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 10-11-2021 To 10-11-2022
✔️ Aurobindo Pharma shares rise after global brokerage upgrades stock to 'buy'
✔️ Aurobindo Pharma bullish on export of Covid drug molnupiravir, its potential in the domestic market
✔️ Aurobindo Pharma posts encouraging US sales recovery during Q2
✔️ Aurobindo Pharma results: Q2 net profit down 14% to Rs 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
✔️ Aurobindo Pharma's Q2 net down 2.1% at 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 06-10-2021 To 10-11-2022
✔️ Aurobindo Pharma Q2 PAT may dip 17.3% YoY to Rs 666.3 cr: Prabhudas Lilladher
✔️ Aurobindo Pharma bullish on export of Covid drug molnupiravir, its potential in the domestic market
✔️ Aurobindo Pharma posts encouraging US sales recovery during Q2
✔️ Aurobindo Pharma results: Q2 net profit down 14% to Rs 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
✔️ Aurobindo Pharma's Q2 net down 2.1% at 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 04-10-2021 To 10-11-2022
✔️ Aurobindo MD's exit alone may not lift stock, new team must start well
✔️ Drug makers Glenmark, Aurobindo Pharma recall products in US market
✔️ Aurobindo Pharma posts encouraging US sales recovery during Q2
✔️ Aurobindo Pharma results: Q2 net profit down 14% to Rs 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
✔️ Aurobindo Pharma's Q2 net down 2.1% at 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 01-10-2021 To 10-11-2022
✔️ Aurobindo Pharma managing director N Govindarajan resigns
✔️ Aurobindo Pharma Managing Director N Govindarajan resigns
✔️ Aurobindo Pharma posts encouraging US sales recovery during Q2
✔️ Aurobindo Pharma results: Q2 net profit down 14% to Rs 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
✔️ Aurobindo Pharma's Q2 net down 2.1% at 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 23-09-2021 To 10-11-2022
✔️ Aurobindo Pharma's subsidiary seeks marketing approval of its first biosimilar product from EMA
✔️ Aurobindo Pharma Managing Director N Govindarajan resigns
✔️ Aurobindo Pharma posts encouraging US sales recovery during Q2
✔️ Aurobindo Pharma results: Q2 net profit down 14% to Rs 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
✔️ Aurobindo Pharma's Q2 net down 2.1% at 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 27-08-2021 To 10-11-2022
✔️ Two stock recommendations from Osho Krishan of Anand Rathi
✔️ Aurobindo Pharma gets USFDA nod for cancer treatment injection
✔️ Aurobindo Pharma share price up nearly 2% on USFDA approval for an injection
✔️ Aurobindo Pharma results: Q2 net profit down 14% to Rs 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
✔️ Aurobindo Pharma's Q2 net down 2.1% at 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 24-08-2021 To 10-11-2022
✔️ Aurobindo Pharma's Cronus rethink is positive, but it needs to do more
✔️ Aurobindo Pharma faces delay in getting its COVID-19 vaccine plan rolling
✔️ Buy Aurobindo Pharma; target of Rs 915: Sharekhan
✔️ Aurobindo Pharma calls off agreement to pick stake in Cronus; stock up 6%
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
✔️ Aurobindo Pharma's Q2 net down 2.1% at 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 23-08-2021 To 10-11-2022
✔️ Aurobindo Pharma: Termination of inorganic bet allays capital allocation concerns
✔️ Aurobindo Pharma shares jump 4% after global research firm retains outperform call
✔️ Buzzing Stocks: Aurobindo Pharma, CarTrade, Cadila Healthcare and other stocks in news today
✔️ Aurobindo Pharma calls off agreement to pick stake in Cronus; stock up 6%
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
✔️ Aurobindo Pharma's Q2 net down 2.1% at 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 20-08-2021 To 10-11-2022
✔️ Aurobindo Pharma Unit-1 gets 7 observations; company says responding to USFDA
✔️ Deal to acquire 51% stake in vet drug firm Cronus cancelled: Aurobindo Pharma
✔️ Aurobindo Pharma says Rs 450-crore deal to acquire 51% in Cronus Pharma cancelled
✔️ Aurobindo Pharma's Rs 450-cr deal to acquire 51% in Cronus Pharma cancelled
✔️ Aurobindo Pharma, Cronus Pharma terminate acquisition deal
✔️ Aurobindo Pharma's Q2 net down 2.1% at 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 17-08-2021 To 10-11-2022
✔️ Aurobindo Pharma hits 52-week low, slips 25% in one month
✔️ Deal to acquire 51% stake in vet drug firm Cronus cancelled: Aurobindo Pharma
✔️ Aurobindo Pharma says Rs 450-crore deal to acquire 51% in Cronus Pharma cancelled
✔️ Aurobindo Pharma's Rs 450-cr deal to acquire 51% in Cronus Pharma cancelled
✔️ Aurobindo Pharma, Cronus Pharma terminate acquisition deal
✔️ Aurobindo Pharma's Q2 net down 2.1% at 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 13-08-2021 To 10-11-2022
✔️ Q1FY22 Result Announced for Aurobindo Pharma Ltd.
✔️ Aurobindo Pharma to invest Rs 420 cr in veterinary firm Cronus for 51% stake
✔️ Aurobindo Pharma dips 5% on weak operational performance in June quarter
✔️ Aurobindo Pharma Q1 consolidated net profit declines 2% to Rs 770 crore
✔️ Aurobindo Pharma, Cronus Pharma terminate acquisition deal
✔️ Aurobindo Pharma's Q2 net down 2.1% at 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 09-08-2021 To 10-11-2022
✔️ Nutanix India registers 24% growth in Q3, onboards NKGSB, Aurobindo Pharma as clients
✔️ Aurobindo Pharma to invest Rs 420 cr in veterinary firm Cronus for 51% stake
✔️ Aurobindo Pharma dips 5% on weak operational performance in June quarter
✔️ Aurobindo Pharma Q1 consolidated net profit declines 2% to Rs 770 crore
✔️ Aurobindo Pharma, Cronus Pharma terminate acquisition deal
✔️ Aurobindo Pharma's Q2 net down 2.1% at 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 05-08-2021 To 10-11-2022
✔️ Aurobindo pharma plans to commercialise Covid19 vaccine, ties up with US-based Vaxxinity
✔️ Aurobindo Pharma looks to commercialise COVID-19 vaccine, expand API production
✔️ Aurobindo Pharma channelising efforts to commercialise COVID-19 vaccine
✔️ Aurobindo Pharma channelising efforts to commercialise Covid-19 vaccine
✔️ Aurobindo Pharma channelising efforts to commercialise COVID-19 vaccine
✔️ Aurobindo Pharma's Q2 net down 2.1% at 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 13-07-2021 To 10-11-2022
✔️ Aurobindo Pharma Q1 PAT seen up 1.3% YoY to Rs 791.1 cr: KRChoksey
✔️ Aurobindo Pharma looks to commercialise COVID-19 vaccine, expand API production
✔️ Aurobindo Pharma channelising efforts to commercialise COVID-19 vaccine
✔️ Aurobindo Pharma channelising efforts to commercialise Covid-19 vaccine
✔️ Aurobindo Pharma channelising efforts to commercialise COVID-19 vaccine
✔️ Aurobindo Pharma's Q2 net down 2.1% at 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 10-07-2021 To 10-11-2022
✔️ Why you should buy Aurobindo Pharma stock
✔️ Aurobindo Pharma looks to commercialise COVID-19 vaccine, expand API production
✔️ Aurobindo Pharma channelising efforts to commercialise COVID-19 vaccine
✔️ Aurobindo Pharma channelising efforts to commercialise Covid-19 vaccine
✔️ Aurobindo Pharma channelising efforts to commercialise COVID-19 vaccine
✔️ Aurobindo Pharma's Q2 net down 2.1% at 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 02-07-2021 To 10-11-2022
✔️ Injectables consolidation could fetch higher valuations for Aurobindo
✔️ Aurobindo Pharma to transfer biz in Unit-4 to arm Eugia Pharma; stock up 4%
✔️ Aurobindo Pharma channelising efforts to commercialise COVID-19 vaccine
✔️ Aurobindo Pharma channelising efforts to commercialise Covid-19 vaccine
✔️ Aurobindo Pharma channelising efforts to commercialise COVID-19 vaccine
✔️ Aurobindo Pharma's Q2 net down 2.1% at 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 04-06-2021 To 10-11-2022
✔️ Accumulate Aurobindo Pharma; target of Rs 1044: KR Choksey
✔️ Aurobindo Pharma to transfer biz in Unit-4 to arm Eugia Pharma; stock up 4%
✔️ Aurobindo Pharma channelising efforts to commercialise COVID-19 vaccine
✔️ Aurobindo Pharma channelising efforts to commercialise Covid-19 vaccine
✔️ Aurobindo Pharma channelising efforts to commercialise COVID-19 vaccine
✔️ Aurobindo Pharma's Q2 net down 2.1% at 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 02-06-2021 To 10-11-2022
✔️ Buy Aurobindo Pharma target of Rs 1139: Prabhudas Lilladher
✔️ Buy Aurobindo Pharma; target of Rs 1165: ICICI Direct
✔️ Lack of near-term triggers to cap upsides in Aurobindo Pharma
✔️ Aurobindo Pharma Edges Lower After Posting Rs 801 Crore Profit In March Quarter
✔️ Buy Aurobindo Pharma: target of Rs 1185: Sharekhan
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 01-06-2021 To 10-11-2022
✔️ What should investors do with Aurobindo Pharma post Q4 results: Buy, sell or hold?
✔️ Aurobindo Pharma Q4 net down 7.2%
✔️ Aurobindo Pharm Consolidated March 2021 Net Sales at Rs 6,001.50 crore, down 2.55% Y-o-Y
✔️ Aurobindo Pharma Edges Lower After Posting Rs 801 Crore Profit In March Quarter
✔️ Buy Aurobindo Pharma: target of Rs 1185: Sharekhan
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 22-04-2021 To 10-11-2022
✔️ Strong injectables portfolio to support Aurobindo Pharma's growth
✔️ Aurobindo Pharma Q4 net down 7.2%
✔️ Aurobindo Pharm Consolidated March 2021 Net Sales at Rs 6,001.50 crore, down 2.55% Y-o-Y
✔️ Aurobindo Pharma Edges Lower After Posting Rs 801 Crore Profit In March Quarter
✔️ Buy Aurobindo Pharma: target of Rs 1185: Sharekhan
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 12-04-2021 To 10-11-2022
✔️ Aurobindo Q4 PAT seen up 6% YoY to Rs. 901 cr: Sharekhan
✔️ Aurobindo Pharma Q4 net down 7.2%
✔️ Aurobindo Pharm Consolidated March 2021 Net Sales at Rs 6,001.50 crore, down 2.55% Y-o-Y
✔️ Aurobindo Pharma Edges Lower After Posting Rs 801 Crore Profit In March Quarter
✔️ Buy Aurobindo Pharma: target of Rs 1185: Sharekhan
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 31-03-2021 To 10-11-2022
✔️ Buy Aurobindo Pharma: target of Rs 1100: Sharekhan
✔️ Aurobindo Pharma Q4 net down 7.2%
✔️ Aurobindo Pharm Consolidated March 2021 Net Sales at Rs 6,001.50 crore, down 2.55% Y-o-Y
✔️ Aurobindo Pharma Edges Lower After Posting Rs 801 Crore Profit In March Quarter
✔️ Buy Aurobindo Pharma: target of Rs 1185: Sharekhan
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 19-02-2021 To 10-11-2022
✔️ Aurobindo Pharma hopes to submit Phase 2/3 data of UB-612 COVID-19 vaccine by July 2021
✔️ Aurobindo Pharma gets USFDA nod for generic Droxidopa capsules
✔️ Weekly Tactical Pick | Aurobindo Pharma
✔️ Aurobindo Pharma Edges Lower After Posting Rs 801 Crore Profit In March Quarter
✔️ Buy Aurobindo Pharma: target of Rs 1185: Sharekhan
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 16-02-2021 To 10-11-2022
✔️ Buy Aurobindo Pharma; target of Rs 1100: Sharekhan
✔️ Aurobindo Pharma gets USFDA nod for generic Droxidopa capsules
✔️ Weekly Tactical Pick | Aurobindo Pharma
✔️ Aurobindo Pharma Edges Lower After Posting Rs 801 Crore Profit In March Quarter
✔️ Buy Aurobindo Pharma: target of Rs 1185: Sharekhan
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 15-02-2021 To 10-11-2022
✔️ Buy Aurobindo Pharma; target of Rs 1165: ICICI Direct
✔️ Aurobindo Pharma gets USFDA nod for generic Droxidopa capsules
✔️ Weekly Tactical Pick | Aurobindo Pharma
✔️ Aurobindo Pharma Edges Lower After Posting Rs 801 Crore Profit In March Quarter
✔️ Buy Aurobindo Pharma: target of Rs 1185: Sharekhan
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 12-02-2021 To 10-11-2022
✔️ Covid-19: Aurobindo Pharma working on multiple' vaccines
✔️ Aurobindo Pharma steady as analysts watch numbers for near-term growth
✔️ Aurobindo Pharma: Vaccine and API plans inject add-on growth levers
✔️ Aurobindo Pharma Edges Lower After Posting Rs 801 Crore Profit In March Quarter
✔️ Buy Aurobindo Pharma: target of Rs 1185: Sharekhan
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 11-02-2021 To 10-11-2022
✔️ Aurobindo Pharm Standalone December 2020 Net Sales at Rs 3,710.86 crore, up 10.92% Y-o-Y
✔️ Aurobindo Pharm Consolidated December 2020 Net Sales at Rs 6,364.91 crore, up 7.97% Y-o-Y
✔️ Aurobindo Pharma Q3 net profit zooms over 4-fold to Rs 2,946.32 crore
✔️ Aurobindo Pharma Q3 net profit zooms over four-fold to Rs 2,946.32 cr
✔️ Aurobindo Pharma Q3 net up 17% at 836 crore
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 25-01-2021 To 10-11-2022
✔️ Aurobindo Pharma's scrip zooms 8%
✔️ Aurobindo Pharma hits 52-week high on approval under PLI
✔️ Aurobindo gains 5% on govt nod for promotion of manufacturing bulk drugs
✔️ Aurobindo Pharma Q3 net profit zooms over four-fold to Rs 2,946.32 cr
✔️ Aurobindo Pharma Q3 net up 17% at 836 crore
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 22-01-2021 To 10-11-2022
✔️ Aurobindo, Kinvan, K'taka Antibiotics first to get PLI for drugs
✔️ Aurobindo Pharma, KAPL get nod for promotion of manufacturing bulk drugs
✔️ Aurobindo gains 5% on govt nod for promotion of manufacturing bulk drugs
✔️ Aurobindo Pharma Q3 net profit zooms over four-fold to Rs 2,946.32 cr
✔️ Aurobindo Pharma Q3 net up 17% at 836 crore
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 18-01-2021 To 10-11-2022
✔️ Aurobindo Pharma Q3 PAT seen up 17.2% YoY to Rs. 719 cr: Prabhudas Lilladher
✔️ Aurobindo Pharma, KAPL get nod for promotion of manufacturing bulk drugs
✔️ Aurobindo gains 5% on govt nod for promotion of manufacturing bulk drugs
✔️ Aurobindo Pharma Q3 net profit zooms over four-fold to Rs 2,946.32 cr
✔️ Aurobindo Pharma Q3 net up 17% at 836 crore
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 28-12-2020 To 10-11-2022
✔️ Here's a Bull Spread Strategy on Aurobindo Pharma by HDFC Securities
✔️ Aurobindo Pharma, KAPL get nod for promotion of manufacturing bulk drugs
✔️ Aurobindo gains 5% on govt nod for promotion of manufacturing bulk drugs
✔️ Aurobindo Pharma Q3 net profit zooms over four-fold to Rs 2,946.32 cr
✔️ Aurobindo Pharma Q3 net up 17% at 836 crore
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 24-12-2020 To 10-11-2022
✔️ Aurobindo Pharma, COVAXX to develop COVID-19 vaccine for India, UNICEF
✔️ Aurobindo Pharma To Make,Sell COVAXX's Covid-19 Vaccine for India, UNICEF
✔️ Aurobindo Pharma enters licensing pact with US biotech COVAXX for manufacture, sale of COVID-19 vaccine
✔️ Aurobindo, COVAXX ink deal to develop, commercialise Covid-19 vaccine for India, UNICEF
✔️ Aurobindo Pharma Q3 net up 17% at 836 crore
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 18-12-2020 To 10-11-2022
✔️ Buy Aurobindo Pharma: target of Rs 1024: Sharekhan
✔️ Aurobindo Pharma To Make,Sell COVAXX's Covid-19 Vaccine for India, UNICEF
✔️ Aurobindo Pharma enters licensing pact with US biotech COVAXX for manufacture, sale of COVID-19 vaccine
✔️ Aurobindo, COVAXX ink deal to develop, commercialise Covid-19 vaccine for India, UNICEF
✔️ Aurobindo Pharma Q3 net up 17% at 836 crore
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 09-12-2020 To 10-11-2022
✔️ Aurobindo Pharma gets USFDA nod for sedative drug
✔️ Aurobindo Pharma To Make,Sell COVAXX's Covid-19 Vaccine for India, UNICEF
✔️ Aurobindo Pharma enters licensing pact with US biotech COVAXX for manufacture, sale of COVID-19 vaccine
✔️ Aurobindo, COVAXX ink deal to develop, commercialise Covid-19 vaccine for India, UNICEF
✔️ Aurobindo Pharma Q3 net up 17% at 836 crore
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 01-12-2020 To 10-11-2022
✔️ Aurobindo says Covid-19 vaccine slightly' delayed; exploring collaborations
✔️ Aurobindo Pharma To Make,Sell COVAXX's Covid-19 Vaccine for India, UNICEF
✔️ Aurobindo Pharma enters licensing pact with US biotech COVAXX for manufacture, sale of COVID-19 vaccine
✔️ Aurobindo, COVAXX ink deal to develop, commercialise Covid-19 vaccine for India, UNICEF
✔️ Aurobindo Pharma Q3 net up 17% at 836 crore
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 29-11-2020 To 10-11-2022
✔️ Aurobindo Pharma expects to commercialise Covid-19 vaccine facility by May
✔️ Aurobindo Pharma To Make,Sell COVAXX's Covid-19 Vaccine for India, UNICEF
✔️ Aurobindo Pharma enters licensing pact with US biotech COVAXX for manufacture, sale of COVID-19 vaccine
✔️ Aurobindo, COVAXX ink deal to develop, commercialise Covid-19 vaccine for India, UNICEF
✔️ Aurobindo Pharma Q3 net up 17% at 836 crore
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 18-11-2020 To 10-11-2022
✔️ Accumulate Aurobindo Pharma; target of Rs 921: Prabhudas Lilladher
✔️ Aurobindo Pharma To Make,Sell COVAXX's Covid-19 Vaccine for India, UNICEF
✔️ Aurobindo Pharma enters licensing pact with US biotech COVAXX for manufacture, sale of COVID-19 vaccine
✔️ Aurobindo, COVAXX ink deal to develop, commercialise Covid-19 vaccine for India, UNICEF
✔️ Aurobindo Pharma Q3 net up 17% at 836 crore
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 17-11-2020 To 10-11-2022
✔️ Buy Aurobindo Pharma; target of Rs 1025: ICICI Direct
✔️ Aurobindo Pharma To Make,Sell COVAXX's Covid-19 Vaccine for India, UNICEF
✔️ Aurobindo Pharma enters licensing pact with US biotech COVAXX for manufacture, sale of COVID-19 vaccine
✔️ Aurobindo, COVAXX ink deal to develop, commercialise Covid-19 vaccine for India, UNICEF
✔️ Aurobindo Pharma Q3 net up 17% at 836 crore
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 12-11-2020 To 10-11-2022
✔️ Aurobindo Pharma rallies 6% as Q2 net profit rises 26% YoY to Rs 805.65 cr
✔️ Aurobindo Pharma shares up 4% after Q2 PAT rises 26% YoY
✔️ Aurobindo Pharma Q2 net up 26% at 806 crore
✔️ Aurobindo Pharma Q2 profit jumps 26% to Rs 805.6 crore; US business grows 12.5%
✔️ Aurobindo Pharma Q3 net up 17% at 836 crore
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 06-11-2020 To 10-11-2022
✔️ Coal mine auction: Aurobindo Reality and Infra wins block in Jharkhand
✔️ Aurobindo Pharma shares up 4% after Q2 PAT rises 26% YoY
✔️ Aurobindo Pharma Q2 net up 26% at 806 crore
✔️ Aurobindo Pharma Q2 profit jumps 26% to Rs 805.6 crore; US business grows 12.5%
✔️ Aurobindo Pharma Q3 net up 17% at 836 crore
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 28-10-2020 To 10-11-2022
✔️ Buy Aurobindo Pharma; target of Rs 985: Motilal Oswal
✔️ Aurobindo Pharma shares up 4% after Q2 PAT rises 26% YoY
✔️ Aurobindo Pharma Q2 net up 26% at 806 crore
✔️ Aurobindo Pharma Q2 profit jumps 26% to Rs 805.6 crore; US business grows 12.5%
✔️ Aurobindo Pharma Q3 net up 17% at 836 crore
✔️ Aurobindo Pharma: US reopening, traction for COVID vaccine near-term growth opportunity
✔️ Aurobindo Pharma, Vaxxinity seek DCGI nod to begin Phase-2/3 of COVID-19 jab UB-612
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 27-10-2020 To 10-11-2022
✔️ Buy Aurobindo Pharma; target of Rs 1025: ICICI Direct
✔️ Top headlines: Aurobindo Pharma to sell Natrol; Navratri drives car sales
✔️ Aurobindo Pharma to sell US-based Natrol for about Rs 4,048 crore
✔️ Divestment of US subsidiary to leave Aurobindo Pharma cash positive
✔️ Aurobindo Pharma inks pact to sell US-based unit for USD 550 mn; shares surge nearly 4%
✔️ Aurobindo Pharma share price rises 4% as subsidiary sells business assets
✔️ Aurobindo to sell US unit to New Mountain Capital for $550 million
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 22-10-2020 To 10-11-2022
✔️ Aurobindo Pharma gets USFDA nod for generic pain killer
✔️ Aurobindo Pharma tumbles over 3% after USFDA warning letter to subsidiary
✔️ Aurobindo Pharma gets USFDA nod for pain treatment injection Acetaminophen
✔️ Divestment of US subsidiary to leave Aurobindo Pharma cash positive
✔️ Aurobindo Pharma inks pact to sell US-based unit for USD 550 mn; shares surge nearly 4%
✔️ Aurobindo Pharma share price rises 4% as subsidiary sells business assets
✔️ Aurobindo to sell US unit to New Mountain Capital for $550 million
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 05-10-2020 To 10-11-2022
✔️ Aurobindo Pharma: Multiple growth triggers to improve Street sentiment
✔️ Aurobindo Pharma tumbles over 3% after USFDA warning letter to subsidiary
✔️ Aurobindo Pharma gets USFDA nod for pain treatment injection Acetaminophen
✔️ Divestment of US subsidiary to leave Aurobindo Pharma cash positive
✔️ Aurobindo Pharma inks pact to sell US-based unit for USD 550 mn; shares surge nearly 4%
✔️ Aurobindo Pharma share price rises 4% as subsidiary sells business assets
✔️ Aurobindo to sell US unit to New Mountain Capital for $550 million
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 28-09-2020 To 10-11-2022
✔️ Buy Aurobindo Pharma; target of Rs 1030: Motilal Oswal
✔️ Aurobindo Pharma tumbles over 3% after USFDA warning letter to subsidiary
✔️ Aurobindo Pharma gets USFDA nod for pain treatment injection Acetaminophen
✔️ Divestment of US subsidiary to leave Aurobindo Pharma cash positive
✔️ Aurobindo Pharma inks pact to sell US-based unit for USD 550 mn; shares surge nearly 4%
✔️ Aurobindo Pharma share price rises 4% as subsidiary sells business assets
✔️ Aurobindo to sell US unit to New Mountain Capital for $550 million
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 23-09-2020 To 10-11-2022
✔️ Buy Aurobindo Pharma; target of Rs 975: Sharekhan
✔️ Aurobindo Pharma tumbles over 3% after USFDA warning letter to subsidiary
✔️ Aurobindo Pharma gets USFDA nod for pain treatment injection Acetaminophen
✔️ Divestment of US subsidiary to leave Aurobindo Pharma cash positive
✔️ Aurobindo Pharma inks pact to sell US-based unit for USD 550 mn; shares surge nearly 4%
✔️ Aurobindo Pharma share price rises 4% as subsidiary sells business assets
✔️ Aurobindo to sell US unit to New Mountain Capital for $550 million
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 16-09-2020 To 10-11-2022
✔️ Aurobindo Pharma: Shot in the arm for Covid vaccine development programme
✔️ MARKET LIVE: Indices likely to open lower; Aurobindo Pharma in focus
✔️ CSIR collaborates with Aurobindo Pharma to develop Covid-19 vaccines
✔️ Aurobindo gears up for multiple Covid-19 vaccines, ties up with CSIR
✔️ Aurobindo Pharma ties up with BIRAC to develop COVID-19 vaccine
✔️ Aurobindo Pharma ties up with BIRAC to develop coronavirus vaccine
✔️ DBT-BIRAC to support Aurobindo Pharma in vaccine development
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 19-08-2020 To 10-11-2022
✔️ Buy Aurobindo Pharma; target of Rs 1027: KR Choksey
✔️ MARKET LIVE: Indices likely to open lower; Aurobindo Pharma in focus
✔️ CSIR collaborates with Aurobindo Pharma to develop Covid-19 vaccines
✔️ Aurobindo gears up for multiple Covid-19 vaccines, ties up with CSIR
✔️ Aurobindo Pharma ties up with BIRAC to develop COVID-19 vaccine
✔️ Aurobindo Pharma ties up with BIRAC to develop coronavirus vaccine
✔️ DBT-BIRAC to support Aurobindo Pharma in vaccine development
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 14-08-2020 To 10-11-2022
✔️ Covid-19 vaccine: Aurobindo expects phase-I, II trials by end of 2020
✔️ MARKET LIVE: Indices likely to open lower; Aurobindo Pharma in focus
✔️ CSIR collaborates with Aurobindo Pharma to develop Covid-19 vaccines
✔️ Aurobindo gears up for multiple Covid-19 vaccines, ties up with CSIR
✔️ Aurobindo Pharma ties up with BIRAC to develop COVID-19 vaccine
✔️ Aurobindo Pharma ties up with BIRAC to develop coronavirus vaccine
✔️ DBT-BIRAC to support Aurobindo Pharma in vaccine development
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 13-08-2020 To 10-11-2022
✔️ Strong US portfolio to drive revenue growth for Aurobindo Pharma
✔️ Aurobindo Pharma declines 4% despite 23% YoY jump in June quarter profit
✔️ Aurobindo Pharma shares fall 3% despite a 22% jump in Q1 profit
✔️ Aurobindo Pharma Q1 net up 23% at 781 cr
✔️ Stocks to watch: Aurobindo Pharma, Indiabulls Group counters, Hero Moto
✔️ Aurobindo Pharma Q1 results: Net profit up 23% to Rs 781 cr
✔️ Aurobindo Pharma Q1 profit jumps 23% to Rs 781 crore
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 11-08-2020 To 10-11-2022
✔️ Poet Rahat Indori dies of cardiac arrest in Indore
✔️ Aurobindo Pharma declines 4% despite 23% YoY jump in June quarter profit
✔️ Aurobindo Pharma shares fall 3% despite a 22% jump in Q1 profit
✔️ Aurobindo Pharma Q1 net up 23% at 781 cr
✔️ Stocks to watch: Aurobindo Pharma, Indiabulls Group counters, Hero Moto
✔️ Aurobindo Pharma Q1 results: Net profit up 23% to Rs 781 cr
✔️ Aurobindo Pharma Q1 profit jumps 23% to Rs 781 crore
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 08-08-2020 To 10-11-2022
✔️ Aurobindo Pharma enters Covid-19 vaccine race
✔️ Aurobindo Pharma declines 4% despite 23% YoY jump in June quarter profit
✔️ Aurobindo Pharma shares fall 3% despite a 22% jump in Q1 profit
✔️ Aurobindo Pharma Q1 net up 23% at 781 cr
✔️ Stocks to watch: Aurobindo Pharma, Indiabulls Group counters, Hero Moto
✔️ Aurobindo Pharma Q1 results: Net profit up 23% to Rs 781 cr
✔️ Aurobindo Pharma Q1 profit jumps 23% to Rs 781 crore
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 07-08-2020 To 10-11-2022
✔️ COVID-19 pandemic: Aurobindo Pharma developing vaccine; gets shortlisted for BIRAC funding
✔️ Aurobindo Pharma working on COVID-19 vaccine; shortlisted for BIRAC funding
✔️ Aurobindo Pharma shares fall 3% despite a 22% jump in Q1 profit
✔️ Aurobindo Pharma Q1 net up 23% at 781 cr
✔️ Stocks to watch: Aurobindo Pharma, Indiabulls Group counters, Hero Moto
✔️ Aurobindo Pharma Q1 results: Net profit up 23% to Rs 781 cr
✔️ Aurobindo Pharma Q1 profit jumps 23% to Rs 781 crore
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 09-07-2020 To 10-11-2022
✔️ Aurobindo Pharma share price at 52-week high on US FDA nod to blood pressure drug
✔️ Aurobindo Pharma working on COVID-19 vaccine; shortlisted for BIRAC funding
✔️ Aurobindo Pharma shares fall 3% despite a 22% jump in Q1 profit
✔️ Aurobindo Pharma Q1 net up 23% at 781 cr
✔️ Stocks to watch: Aurobindo Pharma, Indiabulls Group counters, Hero Moto
✔️ Aurobindo Pharma Q1 results: Net profit up 23% to Rs 781 cr
✔️ Aurobindo Pharma Q1 profit jumps 23% to Rs 781 crore
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 22-06-2020 To 10-11-2022
✔️ Aurobindo Pharma plans to launch 50-60 products in US in FY21
✔️ Despite political tensions, Aurobindo Pharma bullish on business in China
✔️ Aurobindo Pharma shares fall 3% despite a 22% jump in Q1 profit
✔️ Aurobindo Pharma Q1 net up 23% at 781 cr
✔️ Stocks to watch: Aurobindo Pharma, Indiabulls Group counters, Hero Moto
✔️ Aurobindo Pharma Q1 results: Net profit up 23% to Rs 781 cr
✔️ Aurobindo Pharma Q1 profit jumps 23% to Rs 781 crore
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 07-06-2020 To 10-11-2022
✔️ Buy Aurobindo Pharma; target of Rs 880: Motilal Oswal
✔️ Hold Aurobindo Pharma target of Rs 840: Sharekhan
✔️ Aurobindo Pharma shares fall 3% despite a 22% jump in Q1 profit
✔️ Aurobindo Pharma Q1 net up 23% at 781 cr
✔️ Stocks to watch: Aurobindo Pharma, Indiabulls Group counters, Hero Moto
✔️ Aurobindo Pharma Q1 results: Net profit up 23% to Rs 781 cr
✔️ Aurobindo Pharma Q1 profit jumps 23% to Rs 781 crore
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 06-06-2020 To 10-11-2022
✔️ Aurobindo Pharma likely to become debt-free by FY22: Key highlights of concall
✔️ Hold Aurobindo Pharma target of Rs 840: Sharekhan
✔️ Aurobindo Pharma shares fall 3% despite a 22% jump in Q1 profit
✔️ Aurobindo Pharma Q1 net up 23% at 781 cr
✔️ Stocks to watch: Aurobindo Pharma, Indiabulls Group counters, Hero Moto
✔️ Aurobindo Pharma Q1 results: Net profit up 23% to Rs 781 cr
✔️ Aurobindo Pharma Q1 profit jumps 23% to Rs 781 crore
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 05-06-2020 To 10-11-2022
✔️ Aurobindo: Traction in complex generics is vital to its health
✔️ Buy Aurobindo Pharma; target of Rs 870: ICICI Securities
✔️ FDA issues Form 483 with 9 observations to Aurobindo Pharma's USA facility
✔️ Aurobindo Pharma Q1 net up 23% at 781 cr
✔️ Stocks to watch: Aurobindo Pharma, Indiabulls Group counters, Hero Moto
✔️ Aurobindo Pharma Q1 results: Net profit up 23% to Rs 781 cr
✔️ Aurobindo Pharma Q1 profit jumps 23% to Rs 781 crore
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 14-11-2022 To 12-11-2022
✔️ Q2FY23 Quarterly Result Announced for Aurobindo Pharma Ltd.
✔️ Aurobindo Pharma Stock Falls Nearly 7% In Early Trade After Q2 Results
✔️ Aurobindo Pharma slips 7%, hits over 2-year low on weak Q2 results
✔️ Bottomline | The worrisome case of Aurobindo Pharma
✔️ Aurobindo Pharma's Second Quarter Net Profit Falls 41% To Rs 409 Crore
✔️ Aurobindo Pharma's Q2 net down 41% at 409 cr
✔️ Aurobindo Pharma Q2 net down 41% to Rs 409 cr, revenue dips to Rs 5,739 cr
✔️ Aurobindo Pharma Q2 results: Net profit drops 41% to Rs 409 crore
✔️ Aurobindo Pharma Q2 net drops 41% to Rs 409 crore
-: Stock News :- AUROPHARMA 07-12-2022 To 07-12-2022
✔️ Accumulate Aurobindo Pharma; target of Rs 550: Prabhudas Lilladher
-: Stock News :- AUROPHARMA 25-11-2022 To 25-11-2022
✔️ Neutral Aurobindo Pharma; target of Rs 500: Motilal Oswal
-: Stock News :- AUROPHARMA 24-11-2022 To 24-11-2022
✔️ Hold Aurobindo Pharma; target of Rs 540: ICICI Direct
-: Stock News :- AUROPHARMA 21-11-2022 To 21-11-2022
✔️ Aurobindo Pharma plans to complete PLI Penicillin G project worth 2,000 cr by Mar 2024
-: Stock News :- AUROPHARMA 18-11-2022 To 18-11-2022
✔️ Aurobindo Pharma gets USFDA nod for new injection
-: Stock News :- AUROPHARMA 17-11-2022 To 17-11-2022
✔️ Aurobindo Pharma earnings under pressure due to muted performance in US, Europe
-: Stock News :- AUROPHARMA 16-11-2022 To 16-11-2022
✔️ USFDA concludes inspection of Aurobindo Pharma's unit XI
-: Stock News :- AUROPHARMA 31-05-2022 To 10-11-2022
✔️ Earnings Call for Q4FY22 of Aurobindo Pharma Ltd.
✔️ Aurobindo Pharma's Q1 net down 32% at 520 cr
✔️ Aurobindo Pharma's Q1 net down 32% at 520 cr
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ 'Not in any way connected with operations': Aurobindo Pharma on arrest of its promoter by ED
✔️ Delhi liquor scam: Will disclose details after internal probe, says Aurobindo Pharma after promoter's arrest
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 10-02-2022 To 10-11-2022
✔️ Earnings Call for Q3FY22 of Aurobindo Pharma
✔️ Accumulate Aurobindo Pharma; target of Rs 756: KR Choksey
✔️ Aurobindo Pharma buys domestic formulation business of Veritaz for 171 cr
✔️ Aurobindo Pharma acquires Veritaz formulation business for Rs 171 crore
✔️ 'Not in any way connected with operations': Aurobindo Pharma on arrest of its promoter by ED
✔️ Delhi liquor scam: Will disclose details after internal probe, says Aurobindo Pharma after promoter's arrest
✔️ Liquor scam: ED arrests Aurobindo Pharma's Director Sarath Reddy
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 09-11-2021 To 10-11-2022
✔️ Q2FY22 Quarterly Result Announced for Aurobindo Pharma Ltd.
✔️ Aurobindo Pharma bullish on export of Covid drug molnupiravir, its potential in the domestic market
✔️ Aurobindo Pharma posts encouraging US sales recovery during Q2
✔️ Aurobindo Pharma results: Q2 net profit down 14% to Rs 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
✔️ Aurobindo Pharma's Q2 net down 2.1% at 697 cr
✔️ Aurobindo Pharma Q2 net profit declines nearly 14% to Rs 697 crore
✔️ Delhi Excise policy: ED arrests two persons
✔️ Aurobindo Pharma slumps 6% amid reports of Sarath Reddy's arrest by ED
✔️ Delhi liquor case: ED arrests Aurobindo director Sharath Reddy, Pernod Ricard GM Benoy Babu
✔️ Delhi excise policy scam: ED arrests Aurobindo Pharma director Sarath Reddy
-: Stock News :- AUROPHARMA 27-12-2022 To 27-12-2022
✔️ Tergene Biotech gets recommendation from CDSCO subject expert committee for pneumococcal 15-valent vaccine
-: Stock News :- AUROPHARMA 19-01-2023 To 19-01-2023
✔️ Aurobindo Pharma shares fall as USFDA issues 'Form 483' with 2 observations
-: Stock News :- AUROPHARMA 04-01-2023 To 04-01-2023
✔️ Aurobindo Pharma trades in red despite FDA nod to Eugia Pharma injection
-: Stock News :- AUROPHARMA 18-02-2023 To 18-02-2023
✔️ Aurobindo Pharma to make pilot batches in Pen G project by November
-: Stock News :- AUROPHARMA 17-02-2023 To 17-02-2023
✔️ Is there a sign of reversal in Aurobindo Pharma?
-: Stock News :- AUROPHARMA 15-02-2023 To 15-02-2023
✔️ Buy Aurobindo Pharma; target of Rs 565: Prabhudas Lilladher
-: Stock News :- AUROPHARMA 10-02-2023 To 09-02-2023
✔️ Aurobindo Pharma shares gain even as Q3 profit sinks; board declares 300% dividend
✔️ Aurobindo Pharma's consolidated net profit down 18.7% at Rs 491 Cr in Q3
✔️ Aurobindo Pharma Q3 net down 18.7 pc at 491 crore
-: Stock News :- AUROPHARMA 09-02-2023 To 09-02-2023
✔️ Q3FY23 Quarterly Result Announced for Aurobindo Pharma Ltd.
✔️ Aurobindo Pharma's consolidated net profit down 18.7% at Rs 491 Cr in Q3
✔️ Aurobindo Pharma Q3 net down 18.7 pc at 491 crore
-: Stock News :- AUROPHARMA 08-02-2023 To 09-02-2023
✔️ Aurobindo Pharma gets USFDA nod for osteoarthritis drug
✔️ Aurobindo Pharma jumps 5% after subsidiary gets USFDA nod for osteoarthritis pain relief drug
✔️ Aurobindo Pharma Q3 net down 18.7 pc at 491 crore
-: Stock News :- AUROPHARMA 19-01-2023 To 09-02-2023
✔️ Aurobindo Pharma shares fall as USFDA issues 'Form 483' with 2 observations
✔️ Aurobindo Pharma jumps 5% after subsidiary gets USFDA nod for osteoarthritis pain relief drug
✔️ Aurobindo Pharma Q3 net down 18.7 pc at 491 crore
-: Stock News :- AUROPHARMA 04-01-2023 To 09-02-2023
✔️ Aurobindo Pharma trades in red despite FDA nod to Eugia Pharma injection
✔️ Aurobindo Pharma jumps 5% after subsidiary gets USFDA nod for osteoarthritis pain relief drug
✔️ Aurobindo Pharma Q3 net down 18.7 pc at 491 crore
-: Stock News :- AUROPHARMA 27-12-2022 To 09-02-2023
✔️ Tergene Biotech gets recommendation from CDSCO subject expert committee for pneumococcal 15-valent vaccine
✔️ Aurobindo Pharma jumps 5% after subsidiary gets USFDA nod for osteoarthritis pain relief drug
✔️ Aurobindo Pharma Q3 net down 18.7 pc at 491 crore
-: Stock News :- AUROPHARMA 07-12-2022 To 09-02-2023
✔️ Accumulate Aurobindo Pharma; target of Rs 550: Prabhudas Lilladher
✔️ Aurobindo Pharma jumps 5% after subsidiary gets USFDA nod for osteoarthritis pain relief drug
✔️ Aurobindo Pharma Q3 net down 18.7 pc at 491 crore
-: Stock News :- AUROPHARMA 25-11-2022 To 09-02-2023
✔️ Neutral Aurobindo Pharma; target of Rs 500: Motilal Oswal
✔️ Aurobindo Pharma jumps 5% after subsidiary gets USFDA nod for osteoarthritis pain relief drug
✔️ Aurobindo Pharma Q3 net down 18.7 pc at 491 crore
-: Stock News :- AUROPHARMA 24-11-2022 To 09-02-2023
✔️ Hold Aurobindo Pharma; target of Rs 540: ICICI Direct
✔️ Aurobindo Pharma jumps 5% after subsidiary gets USFDA nod for osteoarthritis pain relief drug
✔️ Aurobindo Pharma Q3 net down 18.7 pc at 491 crore
-: Stock News :- AUROPHARMA 21-11-2022 To 09-02-2023
✔️ Aurobindo Pharma plans to complete PLI Penicillin G project worth 2,000 cr by Mar 2024
✔️ Aurobindo Pharma jumps 5% after subsidiary gets USFDA nod for osteoarthritis pain relief drug
✔️ Aurobindo Pharma Q3 net down 18.7 pc at 491 crore
-: Stock News :- AUROPHARMA 18-11-2022 To 09-02-2023
✔️ Aurobindo Pharma gets USFDA nod for new injection
✔️ Aurobindo Pharma jumps 5% after subsidiary gets USFDA nod for osteoarthritis pain relief drug
✔️ Aurobindo Pharma Q3 net down 18.7 pc at 491 crore
-: Stock News :- AUROPHARMA 17-11-2022 To 09-02-2023
✔️ Aurobindo Pharma earnings under pressure due to muted performance in US, Europe
✔️ Aurobindo Pharma jumps 5% after subsidiary gets USFDA nod for osteoarthritis pain relief drug
✔️ Aurobindo Pharma Q3 net down 18.7 pc at 491 crore
-: Stock News :- AUROPHARMA 16-11-2022 To 09-02-2023
✔️ USFDA concludes inspection of Aurobindo Pharma's unit XI
✔️ Aurobindo Pharma jumps 5% after subsidiary gets USFDA nod for osteoarthritis pain relief drug
✔️ Aurobindo Pharma Q3 net down 18.7 pc at 491 crore
-: Stock News :- AUROPHARMA 09-03-2023 To 09-03-2023
✔️ Hold Aurobindo Pharma; target of Rs 516: Sharekhan
-: Stock News :- AUROPHARMA 02-03-2023 To 02-03-2023
✔️ Broker's Call: Aurobindo Pharma (Buy)
✔️ Buy Aurobindo Pharma; target of Rs 554: Geojit
-: Stock News :- AUROPHARMA 18-02-2023 To 02-03-2023
✔️ Aurobindo Pharma to make pilot batches in Pen G project by November
✔️ Buy Aurobindo Pharma; target of Rs 554: Geojit
-: Stock News :- AUROPHARMA 17-02-2023 To 02-03-2023
✔️ Is there a sign of reversal in Aurobindo Pharma?
✔️ Buy Aurobindo Pharma; target of Rs 554: Geojit
-: Stock News :- AUROPHARMA 15-02-2023 To 02-03-2023
✔️ Buy Aurobindo Pharma; target of Rs 565: Prabhudas Lilladher
✔️ Buy Aurobindo Pharma; target of Rs 554: Geojit
-: Stock News :- AUROPHARMA 27-03-2023 To 27-03-2023
✔️ Aurobindo Pharma among 7 stocks that closed above their 200 DMAs
-: Stock News :- AUROPHARMA 14-03-2023 To 14-03-2023
✔️ Neutral Aurobindo Pharma; target of Rs 500: Motilal Oswal
-: Stock News :- AUROPHARMA 16-04-2023 To 16-04-2023
✔️ Aurobindo Pharma Foundation sets up oncology block at MNJ Institute with 80 cr
-: Stock News :- AUROPHARMA 02-06-2023 To 02-06-2023
✔️ Aurobindo Pharma's P Sarath Reddy becomes approver in Delhi liquor case
-: Stock News :- AUROPHARMA 01-06-2023 To 01-06-2023
✔️ Hold Aurobindo Pharma; target of Rs 665: KR Choksey
✔️ Hold Aurobindo Pharma; target of Rs 716: Sharekhan
-: Stock News :- AUROPHARMA 31-05-2023 To 30-05-2023
✔️ Neutral Aurobindo Pharma; target of Rs 600: Motilal Oswal
✔️ Buy Aurobindo Pharma; target of Rs 660: Prabhudas Lilladher
✔️ Aurobindo Pharma share price jumps 7% to 52-week high, up 40% this year; should you buy?
-: Stock News :- AUROPHARMA 30-05-2023 To 30-05-2023
✔️ Brokerages give thumbs up to Aurobindo's investment plans, but valuations pinch
✔️ Buy Aurobindo Pharma; target of Rs 660: Prabhudas Lilladher
✔️ Aurobindo Pharma share price jumps 7% to 52-week high, up 40% this year; should you buy?
-: Stock News :- AUROPHARMA 29-05-2023 To 30-05-2023
✔️ Q4FY23 Quarterly Result Announced for Aurobindo Pharma Ltd.
✔️ Buy Aurobindo Pharma; target of Rs 660: Prabhudas Lilladher
✔️ Aurobindo Pharma share price jumps 7% to 52-week high, up 40% this year; should you buy?
-: Stock News :- AUROPHARMA 27-05-2023 To 30-05-2023
✔️ Aurobindo Pharma posts 12% slump in Q4 net profit at Rs 506 crore, revenue jumps 11%
✔️ Aurobindo Pharma Q4 results: Consolidated PAT dips 12% to 506 crore, revenue up over 11%
✔️ Aurobindo Pharma share price jumps 7% to 52-week high, up 40% this year; should you buy?
-: Stock News :- AUROPHARMA 16-04-2023 To 30-05-2023
✔️ Aurobindo Pharma Foundation sets up oncology block at MNJ Institute with 80 cr
✔️ Aurobindo Pharma Q4 results: Consolidated PAT dips 12% to 506 crore, revenue up over 11%
✔️ Aurobindo Pharma share price jumps 7% to 52-week high, up 40% this year; should you buy?
-: Stock News :- AUROPHARMA 27-03-2023 To 30-05-2023
✔️ Aurobindo Pharma among 7 stocks that closed above their 200 DMAs
✔️ Aurobindo Pharma Q4 results: Consolidated PAT dips 12% to 506 crore, revenue up over 11%
✔️ Aurobindo Pharma share price jumps 7% to 52-week high, up 40% this year; should you buy?
-: Stock News :- AUROPHARMA 14-03-2023 To 30-05-2023
✔️ Neutral Aurobindo Pharma; target of Rs 500: Motilal Oswal
✔️ Aurobindo Pharma Q4 results: Consolidated PAT dips 12% to 506 crore, revenue up over 11%
✔️ Aurobindo Pharma share price jumps 7% to 52-week high, up 40% this year; should you buy?
-: Stock News :- AUROPHARMA 09-03-2023 To 30-05-2023
✔️ Hold Aurobindo Pharma; target of Rs 516: Sharekhan
✔️ Aurobindo Pharma Q4 results: Consolidated PAT dips 12% to 506 crore, revenue up over 11%
✔️ Aurobindo Pharma share price jumps 7% to 52-week high, up 40% this year; should you buy?
-: Stock News :- AUROPHARMA 02-03-2023 To 30-05-2023
✔️ Broker's Call: Aurobindo Pharma (Buy)
✔️ Buy Aurobindo Pharma; target of Rs 554: Geojit
✔️ Aurobindo Pharma share price jumps 7% to 52-week high, up 40% this year; should you buy?
-: Stock News :- AUROPHARMA 18-02-2023 To 30-05-2023
✔️ Aurobindo Pharma to make pilot batches in Pen G project by November
✔️ Buy Aurobindo Pharma; target of Rs 554: Geojit
✔️ Aurobindo Pharma share price jumps 7% to 52-week high, up 40% this year; should you buy?
-: Stock News :- AUROPHARMA 17-02-2023 To 30-05-2023
✔️ Is there a sign of reversal in Aurobindo Pharma?
✔️ Buy Aurobindo Pharma; target of Rs 554: Geojit
✔️ Aurobindo Pharma share price jumps 7% to 52-week high, up 40% this year; should you buy?
-: Stock News :- AUROPHARMA 15-02-2023 To 30-05-2023
✔️ Buy Aurobindo Pharma; target of Rs 565: Prabhudas Lilladher
✔️ Buy Aurobindo Pharma; target of Rs 554: Geojit
✔️ Aurobindo Pharma share price jumps 7% to 52-week high, up 40% this year; should you buy?
No More Records...